other	C0205394//Other//MTH	C0220886//Other location of complaint//MTH	C1271040//Other health professional//MTH	C1521979//Other Route of Drug Administration//MTH	C1546380//Other - Event Reason//MTH	C1546725//Other Specimen Source Code//MTH	C1546836//Other - Special Program Code//MTH	C1546840//Other - Publicity Code//MTH	C1546902//Other - Diagnosis Classification//MTH	C1546930//Other - Report Source//MTH	C1547110//Other - Modality//MTH	C1547196//Other - Organization unit type//MTH	C1547233//Other - Triage Code//MTH	C1547241//Other - Newborn Code//MTH	C1547267//Other - Risk Management Incident Code//MTH	C1547272//Other - Incident Type Code//MTH	C1547281//Other - Production Class Code//MTH	C1547292//Other - Recreational Drug Use Code//MTH	C1547304//Other - Precaution Code//MTH	C1547309//Other - Patient Condition Code//MTH	C1547994//Other - Diagnostic Service Section ID//MTH	C1549063//Other - Notify Clergy Code//MTH	C1549104//Other - Administrative Gender//MTH	C1549110//Other - Marital Status//MTH	C1550146//Other - Substance Type//MTH	C1556042//Other - Relationship//MTH	C1556043//Other - Religion//MTH	C1556044//other - No Information//MTH	C1556045//Other - What subject filter//MTH	C1556046//Other - Employment Status//MTH	C1556048//Other - Contact Role//MTH	C1556049//Other - Mail Claim Party//MTH	C1556050//Other - Living Dependency//MTH	C1556051//Other - Event Consequence//MTH	C1556052//Other - Indirect exposure mechanism//MTH	C1556053//Other - Action Taken in Response to the Event//MTH	C1556054//Other - Status of Evaluation//MTH	C1556055//Other - Causality Observations//MTH	C1556056//Other - Job Status//MTH	C1556057//Other - Immunization Registry Status//MTH	C1561608//Other - Mode of Arrival//MTH	C1868670//Other Growth//MTH	C1996846//Other (qualifier in LNC)//MTH	C2598149//Other:-:Point in time:^Patient:-//MTH	C3496095//Other - HRSA Program//MTH	C3889261//Other License Status//MTH	C4050255//Other Establishment Activity//MTH
the following are appropriate:	
seizures	C0036572//Seizures//MTH
hearing loss	C0011053//Deafness//MTH	C0018772//Hearing Loss, Partial//MTH	C1384666//hearing impairment//MTH	C2029884//hearing loss by exam//MTH	C3887873//Hearing Loss//MTH
skeletal	C0037253//Skeletal system//MTH	C0521324//Skeletal//MTH
cardiovascular	C0007226//Cardiovascular system//MTH	C3887460//Cardiovascular//MTH
respiratory	C0042497//Mechanical Ventilator//MTH	C0521346//respiratory//MTH	C1546767//Specimen Source Codes - Respiratory//MTH
dental	C0011365//Dental Health Services//MTH	C0226984//Dental//MTH	C1272923//Dental dosage form//MTH	C1522187//Dental Route of Drug Administration//MTH	C1547182//School type - Dental//MTH	C1550246//Body Parts - Dental//MTH	C2707315//Dental:-:Point in time:^Patient:-//MTH	C4224066//Specialized Stand Alone Plan - Dental//MTH
treatment includes the following:	
gastrointestinal	C0521362//gastrointestinal//MTH	C1559265//Adverse Event Associated with the Gastrointestinal System//MTH	C2707256//Gastrointestinal:-:Point in time:^Patient:-//MTH
hearing	C0018767//Hearing//MTH	C0018786//Hearing Tests//MTH	C1455844//Hearing examination finding//MTH	C2015933//outcomes otolaryngology hearing//MTH
the following are indicated:	
neurologic	C0205494//Neurologic (qualifier value)//MTH
treatment is symptomatic	
motor dysfunction	C0521654//Neurologic Deficits//MSH
gross motor dysfunction	
consider use of durable medical equipment as needed (e	
fine motor dysfunction	
oral motor dysfunction	
eyes	C0015392//Eye//MTH
skin	C0444099//Skin Specimen//MTH	C1123023//Skin//MTH	C1546781//Skin Specimen Source Code//MTH
developmental pediatricians can provide assistance with transition to adulthood	
some issues to consider:	
renal disease	C0022658//Kidney Diseases//MTH
eye	C0015392//Eye//MTH	C1546630//Eye Specimen Source Code//MTH	C1550636//Eye Specimen//MTH
sensorineural hearing loss	C0018784//Sensorineural Hearing Loss (disorder)//MTH
nutrition	C0028707//Science of nutrition//MTH	C0392209//Nutritional status//MTH	C0518896//Nutrition outcomes//MTH	C0600072//Feeding and dietary regimes//MTH	C1442959//Nutrition function//MTH	C1521729//Nutritional Study//MTH
growth	C0018270//Growth//MTH	C0220844//growth aspects//MTH	C1621966//Tissue Growth//MTH	C2911660//Growth action//MTH
ophthalmologic	C0029087//Ophthalmology specialty//MTH	C0205481//Ophthalmologic//MTH
manifestation	C0205319//Manifest//MTH	C1280464//Manifestation of//MTH
treatment	C0039798//therapeutic aspects//MTH	C0087111//Therapeutic procedure//MTH	C1522326//Treating//MTH	C1533734//Administration procedure//MTH	C1705169//Biomaterial Treatment//MTH	C3161471//Treatment Study//MTH	C3538994//Treatment Epoch//MTH	C3887704//treatment - ActInformationManagementReason//MTH
communication issues	C0681295//Communication issue//MDR
and	C0002838//Andorra//MTH	C1515981//And//MTH	C1550557//RelationshipConjunction - and//MTH	C1706368//And - dosing instruction fragment//MTH
craniofacial	C0596392//craniofacial//CHV
hypothyroidism	C0020676//Hypothyroidism//MTH
treatment is supportive	
forearm crutches or canes for gait stability	
special shoes, including those with good ankle support	
5 g/m2	
table 3	
considerations/other	
standard recommendations may vary from country to country	
ages 0-3 years	
ages 3-5 years	
ages 5-21 years	
all ages	
liver transplantation	C0023911//Transplantation of liver//MTH
canes and walkers help prevent falls	
no specific therapy is available	
renal	C0022646//Kidney//MTH
cardiomyopathy	C0878544//Cardiomyopathies//MTH
intellectual disability	C3714756//Intellectual Disability//MTH
ataxia	C0004134//Ataxia//MTH	C0007758//Cerebellar Ataxia//MTH
special education	C0013649//Special Education//MTH
failure to thrive	C0015544//Failure to Thrive//MTH	C2315100//Pediatric failure to thrive//MTH	C3887638//Failure to thrive in infant//MTH
developmental delay	C0424605//Developmental delay (disorder)//MTH	C0557874//Global developmental delay//MTH
1-0	
treatment is symptomatic and may include the following:	
dystonia	C0013421//Dystonia//MTH	C0393593//Dystonia Disorders//MTH
in the united states:	
consider evaluation for alternative means of communication (e	
yes	C0919479//YES1 gene//MTH	C1298907//Yes - Presence findings//MTH	C1546945//Yes - Event Seriousness//MTH	C1546947//Yes - Event Expected//MTH	C1546969//Yes - Identity May Be Divulged//MTH	C1548171//Yes - Release Information//MTH	C1549060//Yes - Expanded yes/no indicator//MTH	C1549065//Yes - Notify Clergy Code//MTH	C1549443//Yes - Assignment of Benefits//MTH	C1549445//Yes - Yes/no indicator//MTH	C1705108//Yes (indicator)//MTH
short stature	C0013336//Dwarfism//MTH	C0349588//Short stature//MTH	C2237041//SHOX gene with short stature//MTH	C2919142//Short Stature Adverse Event//MTH
endocrine	C0014136//Endocrine system//MTH	C0521425//Endocrine//MTH	C0553665//Skin endocrine disorder//MTH	C1559198//Adverse Event Associated with Endocrine//MTH
neurologic manifestations	C0027854//Neurologic Manifestations//MSH
pulmonary	C0024109//Lung//MTH	C2707265//Pulmonary:-:Point in time:^Patient:-//MTH	C2709248//Pulmonary (qualifier value)//MTH
cancer	C0006826//Malignant Neoplasms//MTH	C0260515//Family history of cancer//MTH	C0998265//Cancer Genus//MTH	C1306459//Primary malignant neoplasm//MTH	C1547140//Specialty Type - cancer//MTH	C2707253//Cancer:-:Point in time:^Patient:-//MTH
physical therapy	C0029709//Encounter due to other physical therapy//MTH	C0699718//Physical therapy (field)//MTH	C0949766//Physical therapy//MTH	C1547999//Diagnostic Service Section ID - Physical Therapy//MTH
renal anomalies	C0266292//Congenital anomaly of the kidney//SNOMEDCT_US
deafness	C0011053//Deafness//MTH	C0018772//Hearing Loss, Partial//MTH
5-1	
treatment follows routine practices	
speech therapy	C0009460//Communication impairment//MTH	C0037831//Speech Therapy//MTH	C0699719//Encounter due to speech therapy//MTH
some individuals require forearm crutches or canes for gait stability	
cardiac	C0018787//Heart//MTH	C1522601//Cardiac - anatomy qualifier//MTH
caregivers	C0085537//Caregiver//MTH
heart defects	C0018798//Congenital Heart Defects//MTH
psychotropic medication may also be indicated	
constipation	C0009806//Constipation//MTH	C1963087//Constipation Adverse Event//MTH	C3641755//Have Constipation//MTH	C4084722//How Often Constipation//MTH	C4084723//How Much Distress Constipation//MTH	C4084724//Usual Severity Constipation//MTH
antiepileptic drugs	C0003299//Antiepileptic Agents//MTH
musculoskeletal	C0497254//Musculoskeletal//MTH	C2707260//Musculoskeletal:-:Point in time:^Patient:-//MTH
spasticity	C0026838//Muscle Spasticity//MTH
global developmental disability / intellectual disability educational issues	
private supportive therapies based on the affected individual’s needs	
medications	C0013227//Pharmaceutical Preparations//MTH	C0802604//Medications:Presence or Identity:Duration of the study:^Patient:Nominal//MTH	C2598133//Medications:-:Point in time:^Patient:-//MTH	C4284232//Medications//MTH
0-3	
developmental	C0458003//Developmental (qualifier value)//MTH	C0678723//Biologic Development//MTH
8-2	
gerd = gastroesophageal reflux disease	
hydrocephalus	C0020255//Hydrocephalus//MTH	C1963137//Hydrocephalus Adverse Event//MTH
adrenal insufficiency	C0001623//Adrenal gland hypofunction//MTH	C0405580//Adrenal cortical hypofunction//MTH	C1963059//Adrenal Insufficiency Adverse Event//MTH
hypertension	C0020538//Hypertensive disease//MTH	C1963138//Hypertension Adverse Event//MTH
liver disease	C0023895//Liver diseases//MTH	C2186532//reported prior liver disease (history)//MTH
hepatic disease	C0023895//Liver diseases//MTH
pulmonary disease	C0024115//Lung diseases//MTH	C0455540//History of - respiratory disease//MTH
renal manifestations	
hyperlipidemia	C0020473//Hyperlipidemia//MTH	C0020476//Hyperlipoproteinemias//MTH	C0428465//Serum lipids high (finding)//MTH
bleeding	C0019080//Hemorrhage//MTH
dialysis	C0011945//Physical Dialysis//MTH	C0011946//Dialysis procedure//MTH	C1059964//Genus Dialysis//MTH	C1654851//dialysis device//MTH
surgical stabilization of the spine may be required	
pectus excavatum can be severe	
optic atrophy	C0029124//Optic Atrophy//MTH
appropriate treatment includes the following:	
diabetes mellitus	C0011849//Diabetes Mellitus//MTH
for ages 0-3 years	
for ages 3-5 years	
for ages 5-21 years	
for all ages	
social/behavioral difficulties	
05-0	
weight control to avoid obesity	
feeding difficulties	C0232466//Feeding difficulties//MTH
osteopenia	C0005944//Metabolic Bone Disorder//MTH	C0029453//Osteopenia//MTH
management is supportive	
development	C0020119//Human Development//MTH	C0243107//development aspects//MTH	C0678723//Biologic Development//MTH	C1527148//Development//MTH	C3272564//Development Lot//MTH
exocrine pancreatic insufficiency	C0267963//Exocrine pancreatic insufficiency//MTH
anemia	C0002871//Anemia//MTH	C1000483//Genus Anemia//MTH
malignancy	C0006826//Malignant Neoplasms//MTH	C1306459//Primary malignant neoplasm//MTH	C4282132//Malignancy//MTH
exercise within the individual's capability	
fewer than 5% need wheelchairs	
symptomatic treatment	
5-0	
0 g/m2	
audiologic	
fitting with appropriate hearing aids	
enrollment in an appropriate educational program for the hearing impaired	
growth hormone deficiency	C0271561//Somatotropin deficiency//MTH	C3714796//Isolated somatotropin deficiency//MTH
tolerance to different primary layers varies	
nonstick products (e	
silicone-based products without adhesive (e	
rolls of gauze (e	
cleft palate	C0008925//Cleft Palate//MTH	C1837218//Cleft palate, isolated//MTH	C2240378//cleft palate on exam//MTH	C2981150//Uranostaphyloschisis//MTH
table 5	
neutropenia	C0023530//Leukopenia//MTH	C0027947//Neutropenia//MTH	C0853697//Neutrophil count decreased//MTH
physical therapy is recommended to maximize mobility	
no specific treatment is available	
prevention of secondary manifestations	
ketogenic diet	C0259972//Ketogenic Diet//MTH
7-2	
pediatric issues	
liver	C0023884//Liver//MTH	C0023899//Liver Extract//MTH	C0721399//Liver brand of Vitamin B 12//MTH	C1278929//Entire liver//MTH	C2346688//Liver Flavor//MTH
sodium benzoate	C0142805//Sodium Benzoate//MSH
table 4	
orthopedic	C0029355//Orthopedics//MTH
supportive therapy includes the following:	
use of respiratory aids when indicated	
genitourinary abnormalities	C0042063//Urogenital Abnormalities//MTH
epilepsy	C0014544//Epilepsy//MTH
see hereditary hearing loss and deafness	
supportive and symptomatic management is indicated	
9-2	
2(1	
0(1	
5-2	
7-4	
surgery	C0038894//Surgery specialty//MTH	C0038895//Surgical aspects//MTH	C0543467//Operative Surgical Procedures//MTH	C1274039//General surgery specialty//MTH	C1457907//Surgical procedure finding//MTH	C1547138//Level of Care - Surgery//MTH	C1705196//Surgery Domain//MTH
dysphagia	C0011168//Deglutition Disorders//MTH
vision	C0042789//Vision//MTH	C2707266//Vision:-:Point in time:^Patient:-//MTH	C4085584//Specialized Stand Alone Plan - Vision//MTH
hypogonadism	C0020619//Hypogonadism//MTH
care by a pediatric endocrinologist is recommended	
standard management	
craniosynostosis	C0010278//Craniosynostosis//MTH
org)	
obesity	C0028754//Obesity//MTH	C1963185//Obesity Adverse Event//MTH
obstructive sleep apnea	C0520679//Sleep Apnea, Obstructive//MTH
ocular	C0015392//Eye//MTH	C0042789//Vision//MTH	C0700042//Orbital region//MTH	C1299003//Ocular (qualifier)//MTH
cleft lip/palate	C0158646//Cleft palate with cleft lip//MTH
chronic treatment	
hypogonadotropic hypogonadism	C0022735//Klinefelter Syndrome//MTH	C0271623//Hypogonadotropic hypogonadism//MTH
other treatments	
movement disorder	C0026650//Movement Disorders//MTH
lung disease	C0024115//Lung diseases//MTH
no definitive treatments for the limb-girdle muscular dystrophies exist	
thrombocytopenia	C0040034//Thrombocytopenia//MTH
reducing the risk of neurologic damage	
see deafness and hereditary hearing loss overview, management	
immunodeficiency	C0021051//Immunologic Deficiency Syndromes//MTH	C4284394//Immunodeficiency:Type:Pt:^Patient:Nom//MTH
some symptoms (e	
bone marrow transplantation	C0005961//Bone Marrow Transplantation//MTH
symptoms typically resolve within days	
bone marrow transplantation (bmt)	
education of parents regarding common seizure presentations is appropriate	
, contractures, scoliosis, hip dislocation)	
parkinsonism	C0242422//Parkinsonian Disorders//MTH
other features	
ovarian insufficiency	C0747102//Ovarian failure//MTH	C1401084//Ovarian Insufficiency//MTH
infertility	C0021359//Infertility//MTH
cardiac defects are managed in a routine manner	
the following are recommended:	
precocious puberty	C0034013//Precocious Puberty//MTH
physical therapy and rehabilitation to improve motor function	
they can tolerate carbohydrates, fats, and protein	
oral motor dysfunction with persistent vomiting	
consultation with a gastroenterologist and nutritionist is often necessary	
"infantile catastrophic phase	
strabismus	C0038379//Strabismus//MTH	C1423541//VANGL2 gene//MTH	C2020541//strabismus on exam (physical finding)//MTH
stroke-like episodes	C1857287//Stroke-like episode//HPO
coagulopathy	C0005779//Blood Coagulation Disorders//MTH
deep venous thrombosis (dvt)	
independent living issues	
0-2	
ocular manifestations	
aeruginosa in airway cultures	
bronchodilator	C0006280//Bronchodilator Agents//MSH
hypertonic saline	C0036085//Saline Solution, Hypertonic//MTH
dornase alfa	C1135662//Dornase Alfa//MTH
airway clearance	
fertility	C0015895//Fertility//MTH	C0200069//Infertility study//MTH	C2986895//Fertility Domain//MTH
refractive errors may be managed with spectacles or contact lenses	
to improve alignment in primary gaze position	
colitis	C0009319//Colitis//MTH	C1963084//Colitis Adverse Event//MTH
antidepressants are often required to treat concurrent depression	
ocular abnormalities	
services provided vary based on age and needs	
physical and occupational therapy	
ventilatory support	
daily heel cord stretching exercises to prevent achilles tendon shortening	
orthopedic surgery	C0029355//Orthopedics//MTH	C0162439//Orthopedic Surgery (discipline)//MTH	C1136201//Orthopedic Surgical Procedures//MTH
fewer than 5% of individuals need wheelchairs	
respiratory dysfunction	C1260922//Abnormal breathing//MTH
odontoid hypoplasia	C1846439//Hypoplasia of the odontoid process//HPO
exercise within the individual's capability to remain physically active	
hearing aids as needed	
management includes the following:	
0 mm in diameter	
pharmacologic treatment	
central nervous system	C3540014//CENTRAL NERVOUS SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS//MTH	C3714787//Central Nervous System//MTH
cognitive	C1516691//Cognitive//NCI
endocrinopathies	C0014130//Endocrine System Diseases//MTH
spine	C0037949//Vertebral column//MTH	C2752558//Neuron spine//MTH
sodium benzoate: 250 mg/kg or 5	
sodium phenylacetate: 250 mg/kg or 5	
10% arginine hcl: 600 mg/kg or 12	
reversal of catabolism	
gastroesophageal reflux should be addressed in a standard manner	
ophthalmologic abnormalities are treated in the standard manner	
skeletal abnormalities (e	
hearing loss is treated with a trial of hearing aids	
infants benefit from enrollment in an early-intervention program	
pulmonary fibrosis	C0034069//Pulmonary Fibrosis//MTH
thiamine	C0039840//Thiamine//MTH	C0373727//Thiamine Assay//MTH	C3714802//Thiamine Drug Class//MTH
riboflavin	C0035527//Riboflavin//MTH	C0373720//Riboflavin Assay//MTH	C3714502//Riboflavin Drug Class//MTH
initial treatment	
long-term medical management	
levodopa	C0023570//Levodopa//MTH
treatment of psychiatric problems with appropriate psychotropic medications	
adaptation of environment and care to the level of dementia	
individuals with severe heart block may require pacemaker implantation	
growth retardation	C0151686//Growth retardation//MTH
feeding therapy	
oral medications are usually tried first:	
baclofen (lioresal®)	
benzodiazepines	C0005064//Benzodiazepines//MTH	C0373486//Benzodiazepines Assay//MTH	C4048284//Benzodiazepine//MTH
primary layers include the following:	
, telfa®, n-terface®)	
, mepitel®, mepilex®)	
, kerlix®) are commonly used	
hypotrichosis	C0020678//Hypotrichosis//MTH
see prevention of primary manifestations	
hematologic	C0018943//Hematology (discipline)//MTH	C0205488//Hematologic//MTH
treatment of manifestations in individuals with ethylmalonic encephalopathy	
gorman et al [2016]	
enrollment in developmental disabilities administration (dda) is recommended	
hernia	C0019270//Hernia//MTH
arterial abnormalities	C0151489//Arterial malformation//MTH
acute photosensitivity	
grey or smoke-colored filters provide only partial protection	
topical sunscreens are typically not useful	
close monitoring is warranted	
treatment of thrombosis in children	
antoun et al [2016]	
huemer et al [2015]	
the following measures are appropriate:	
referral of the family to support groups and other resources	
cryptorchidism	C0010417//Cryptorchidism//MTH
dental problems	C0576962//Tooth problem//SNOMEDCT_US
pain	C0006138//Bread//MSH	C0030193//Pain//MTH	C0518090//Frequency of Pain Question//MTH	C1549543//Administration Method - Pain//MTH	C1557397//Adverse Event Associated with Pain//MTH	C1882272//Pain Adverse Event by CTCAE Anatomic Descriptor//MTH	C2598155//Pain:-:Point in time:^Patient:-//MTH	C2984058//Have Pain//MTH	C4085210//Usual Severity Pain//MTH	C4085211//Pain Distress Question//MTH	C4085212//How Much Distress Pain//MTH
thus, good sleep hygiene should be encouraged	
corticosteroids	C0001617//Adrenal Cortex Hormones//MTH	C3539185//Corticosteroid nasal preparations for topical use//MTH	C3540725//Corticosteroid otologicals//MTH	C3540726//Corticosteroid ophthalmologic and otologic preparations//MTH	C3540727//Corticosteroids, topical for treatment of hemorrhoids and anal fissures//MTH
immunoglobulins	C0021027//Immunoglobulins//MTH	C0202081//Immunoglobulin measurement//MTH
educational programming directed to the specific disabilities identified	
cardiac manifestations	
intramuscular injections should be avoided unless under factor coverage	
dermatologic	C0205489//Dermatologic//SNOMEDCT_US
cataract	C0086543//Cataract//MTH	C1690964//cataract on exam (physical finding)//MTH	C1962983//Cataract Adverse Event//MTH
250 mg/kg/day	
sodium phenylacetate	C0142910//sodium phenylacetate//MTH
mechanisms of drug action in treatment of hyperammonemia	
raises insulin levels	
induces anabolic state	
causes protein sparing effect from skeletal muscle amino acids	
stimulates secretion of insulin	
eliminates one amino group in the urine	
eliminates two amino groups in the urine	
a non-essential amino acid in humans	
surgical management	C1515089//Surgical Management//NCI
renal and liver function	
full blood count	C0009555//Complete Blood Count//MTH
psychological support	C0600015//Emotional support//MTH
table 7	
principles of treatment for individuals with hokpp	
add 0	
3 meq/kg/h	
(2) in the work setting	
myopathy	C0026848//Myopathy//MTH
behavior	C0004927//Behavior//MTH	C2707008//Behavior:-:Point in time:^Patient:-//MTH
drugs to reduce muscle spasticity (e	
, oxybutynin)	
cd46	C0285488//CD46 Antigen//MTH	C1824669//CD46 gene//MTH
cfh	C1538440//CFH gene//MTH
dgke	C1414032//DGKE gene//MTH
thbd	C1420720//THBD gene//MTH
hyperuricemia/gout	
lifelong therapy with allopurinol may be required	
the transplanted kidney does not develop the disease	
current recommended drug therapies for adults with fh	
15% 1, 3	
50% 5	
often ineffective in hofh	
kastelein et al [2008]	
rader et al [2003]	
approved only for adults with hofh	
cuchel et al [2014]	
raal & santos [2012]	
physical therapy to improve motor function	
pharmacologic treatment of spasticity and seizures	
maintenance therapy	C0677908//Maintenance therapy//SNOMEDCT_US
genital anomalies	C0744356//Abnormality of the genital system//HPO
surgery as required	
routine management	
thyroid hormone replacement as needed	
treatment of manifestations in individuals with kcnk9 imprinting syndrome	
standard treatment for scoliosis	
developmental disabilities administration (dda) enrollment is recommended	
social/behavioral issues	
therapeutic management of the sleep disorder	
management of seizures in accordance with standard practice	
auditory amplification if hearing loss is identified	
gonadotropin therapy	
spastic paraplegia	C0037772//Spastic Paraplegia//MTH
general guidelines can be followed	
antiepileptic drugs (aed) if epileptic seizures are present	
acidosis	C0001122//Acidosis//MTH	C0220981//Metabolic acidosis//MTH
psychological support for the affected individual and family is essential	
feeding	C0204695//Feeding patient//MTH	C2148613//feeding of newborn//MTH	C2987508//Feeding Activity//MTH	C3714845//feeding (treatment)//MTH	C4318653//Feeding Ability Question//MTH
psychomotor development	C0392358//Psychomotor development//SNOMEDCT_US
gerd	C0017168//Gastroesophageal reflux disease//MTH
neurobehavioral symptoms	
the choice should be left to personal preference	
dural ectasia is usually asymptomatic	
no effective therapies for symptomatic dural ectasia currently exist	
hernias tend to recur after surgical intervention	
long-term treatment	C0023977//long-term care//MTH
genitourinary	C0042066//Genitourinary system//MTH	C2707257//Genitourinary:-:Point in time:^Patient:-//MTH	C2709258//Genitourinary Route of Drug Administration//MTH	C3887515//Genitourinary//MTH
joint contractures	C0009918//Contracture of joint//SNOMEDCT_US
developmental delay/cognitive impairment	
specialized learning programs to meet individual needs	
no specific antiepileptic or antipsychotic medications are indicated	
cardiac malformations	C4228353//Cardiac malformations//OMIM
treatment should follow standard practice	
see hereditary hearing loss and deafness overview	
congenital heart defects	C0018798//Congenital Heart Defects//MTH
stretching exercises are ineffective and painful	
the following treatment is appropriate:	
joints	C0022417//Joints//MTH	C0392905//Articular system//MTH
reasons for 28 hospitalizations in 15 infants with msud	
strauss et al [2010]	
4(2	
3(1	
1(1	
5-6	C3843715//5-6//LNC
3-9	
3-1	
0(3	
7(3	
7-7	
2(5	
50(0	
43-0	
58)	
from strauss et al [2010]	
with permission from elsevier	
acute pancreatitis	C0001339//Acute pancreatitis//SNOMEDCT_US
infection	C0009450//Communicable Diseases//MTH	C1556682//Adverse Event Associated with Infection//MTH	C3714514//Infection//MTH
see hirschsprung disease overview	
cataracts	C0086543//Cataract//MTH	C0521707//Bilateral cataracts (disorder)//MTH
deep brain stimulation (dbs)	
cataracts can be removed if they impair vision	
other tumors	
photodysphoria (discomfort in bright light	
orthopedic treatment	
dental treatment	C0011331//Dental Procedures//MTH
treatment of decreased visual acuity is symptomatic (e	
, low-vision aids)	
250 mg/kg	
5,500 mg/m2	
batshaw et al [2001]	
loading dose given over 90 to 120 minutes	
maintenance dose given over 24 hours	
the typical dilution is 1:10	
arginine infusion not to exceed 150mg/kg/h	
surgery has been reported to be helpful by many patients	
fecal elastase-1 analysis (schebo® biotech ag	
, cck-8) or receptor agonists (e	
their nature (e	
blocking of pancreatic lipase (e	
diseases of the intestinal mucosa	
diffusion-weighted mri	C0598801//Diffusion weighted imaging//MTH
monitoring for glucose intolerance	
hypoventilation	C3203358//Hypoventilation//MTH
consider aspirin treatment	
severe atp8b1 deficiency	
mild atp8b1 deficiency	
reduction of calcium oxalate supersaturation	
organ transplantation	C0029216//Organ Transplantation//MTH
only if affected person is known to be b6 responsive	
from cochat et al [2012]	
recommendations assume the availability of facilities	
pox= plasma oxalate	
see note	
visual impairment	C0042798//Low Vision//MTH	C3665347//Visual Impairment//MTH
cys282tyr / p	
treatment of medical manifestations in individuals with ptls	
standard treatment as recommended by dentist/orthodontist	
poor weight gain / failure to thrive	
global developmental delay / intellectual disability educational issues	
, orthotics, adaptive strollers)	
chemotherapy	C0013216//Pharmacotherapy//MTH	C0013217//pharmacotherapeutic//MTH	C0392920//Chemotherapy Regimen//MTH	C3665472//Chemotherapy//MTH
5 years	
joint pain	C0003862//Arthralgia//MTH	C1963066//Joint Pain Adverse Event//MTH	C4085641//Level of Joint Pain//MTH
see published guidelines/consensus statements	
treatment of manifestations in individuals with pura-related neurodevelopmental disorders	
scoliosis	C0036439//Scoliosis, unspecified//MTH	C0559260//Congenital scoliosis//MTH	C0700208//Acquired scoliosis//MTH
sleep	C0037313//Sleep//MTH	C0723362//Sleep brand of diphenhydramine hydrochloride//MTH
skeletal abnormalities	C4021790//Abnormality of the skeletal system//HPO
treatments include the following:	
standard treatment with antiepileptic drugs for seizures	
physical, occupational, and speech therapies, if necessary	
standard treatment is indicated	
treatment of manifestations in individuals with trio-related intellectual disability	
treatment of manifestations in individuals with unc80 deficiency	
see retinitis pigmentosa overview, management	
educational support	
hearing impairment	C1384666//hearing impairment//MTH	C1550444//Person Disability Type - Hearing impaired//MTH
medical measures	
early use of antibiotics for bacterial infections	
insertion	C0021107//Implantation procedure//MTH	C0441587//Clinical act of insertion//MTH	C1512796//Insertion Mutation//MTH	C1883719//Insert (object)//MTH
physiotherapy including hydrotherapy to avoid strain on the joints	
use of a wheelchair if necessary	
orthopedic intervention if necessary	
special shoes may help with ankle and foot support	
therefore, ventriculocaval shunts are preferred	
educational opportunities/social considerations	
use of sign language in individuals with significant hearing loss	
early educational intervention for development of social skills	
speech therapy to improve speech	
special education to maximize learning	
planning housing for possible future wheelchair use	
hbh disease	
cortisol deficiency	C4285817//Cortisol deficiency//MDR
genital abnormalities	C0744356//Abnormality of the genital system//HPO
hypospadias and cryptorchidism may be corrected with surgery	
vaginal reconstruction may be performed in females with vaginal hypoplasia	
ovarian cysts	C0029927//Ovarian Cysts//MTH
nasal stints or tracheotomy may be required	
joint contractures and elbow synostosis	
early developmental/educational intervention is appropriate for cognitive delays	
low-dose neuroleptics may be useful for psychiatric manifestations	
referral for psychiatric evaluation is appropriate	
low vision aids include high-powered magnifiers for reading	
achromat	
provide palliative care for viable newborns	
only modest effects on adult stature seem to accrue	
measures to avoid obesity should start in early childhood	
craniocervical junction constriction	
the best predictors of need for suboccipital decompression include:	
lower-limb hyperreflexia or clonus	
central hypopnea demonstrated by polysomnography	
treatment may include the following:	
adenotonsillectomy	C0193959//Tonsillectomy and adenoidectomy//SNOMEDCT_US
weight reduction	C1262477//Weight decreased//MTH
continuous positive airway pressure	C0199451//Continuous Positive Airway Pressure//MTH
tracheostomy for extreme cases	
middle ear dysfunction	
varus deformity	C0432593//Varus angulation//SNOMEDCT_US
various interventions may be elected (e	
kyphosis	C0022821//Kyphosis deformity of spine//MTH	C0022822//Acquired kyphosis//MTH	C0265673//Congenital kyphosis//MTH	C2115817//kyphosis//MTH
spinal stenosis	C0037944//Spinal Stenosis//MTH	C1861329//Spinal canal stenosis//MTH
socialization	C0037447//Socialization//MSH
desferrioxamine	C0011145//Deferoxamine//MSH
treatment with iron chelating agents (i	
deferasirox	C1619629//deferasirox//MSH
deferiprone	C0043832//deferiprone//MTH
fresh-frozen human plasma	
if the serum potassium concentration is low (<3	
treatment for actg2-related disorders remains supportive	
urologic manifestations	
management of bladder dysfunction by an urologist is recommended	
gastrointestinal manifestations	
however, bladder catheterization was still required	
prophylaxis for pneumocystis jiroveci	
intravenous immunoglobulin (ivig)	
cutaneous/cranial	
wounds without calvarial involvement	
plastic wrap (e	
, duoderm®)	
other less preferred, less costly dressings are:	
wounds with calvarial defects: acute care	
wounds with calvarial defects: late calvarial reconstruction	
limb	C0015385//Limb structure//MTH
early physiotherapy can maximize motor function and range of motion	
management of seizures is per routine	
if typical signs (e	
medication has been variably effective in suppressing debilitating symptoms	
j friedman, personal observation]	
fm hisama, personal observation]	
stress management	C0150788//Stress management//SNOMEDCT_US
intrafamilial variation in pharmaco-responsiveness occurs	
therefore, all appropriate aeds should be tried	
speech, occupational, and physical therapy	
specialized learning programs depending on individual needs	
nutritional support if necessary	
routine treatment of cardiac and ophthalmologic findings	
ankyloblepharon filiforme adnatum	C1302999//Ankyloblepharon filiforme adnatum//MTH	C1412271//AFA gene//MTH
larger ones may require surgical separation by an ophthalmologist	
ectodermal defects	
skin erosions	C3887524//Skin Erosion//MTH
empiric treatment (i	
clefting should be addressed as soon as developmentally possible	
chest physiotherapy and vigorous treatment of respiratory complications	
management of seizures using standard protocols	
acute episodes	
correction of hyperkalemia may be needed	
, solu-cortef®)	
adequate sodium must be provided	
treatment during stress	
, intercurrent illness, surgery, trauma)	
glucose and sodium may be needed	
parents should have access to rapid medical advice	
guidelines for hospital admission should be clear	
acth levels should normalize when replacement therapy is adequate	
acute neurovisceral attack	
clinical assessment should include a full neurologic evaluation	
investigations should include:	
full blood count (fbc)	
serum and urine osmolality	
urine sodium concentration if hyponatremic	
, crp, blood cultures, ck, magnesium	
mri should be considered if cns symptoms are present	
general measures	
see agents/circumstances to avoid	
restore energy balance using an enteral route if possible	
treat intercurrent infections and other diseases promptly	
supportive treatment	
pain relief	C0451615//Pain relief//MTH	C0722420//Pain Relief brand of acetaminophen//MTH
nausea and vomiting	C0027498//Nausea and vomiting//MTH
prochloperazine, promazine or ondansetron are considered safe	
beta blockers are considered safe	
fluid balance and electrolytes	
dextrose saline is preferred	
specific treatment	
it is infused over at least 30 minutes	
recurrent acute attacks	
gynecological review and bone density monitoring are recommended	
prophylactic hemin infusion	
however, evidence for clinical efficacy remains elusive	
, medicalert® or similar)	
see resources	
liver transplantation for end-stage liver disease has an 80	
cardiac involvement is treated in a standard manner	
renal anomalies are treated in a standard manner	
vascular accidents should be treated in a standard manner	
head injuries and neurologic symptoms should be evaluated aggressively	
ophthalmologic abnormalities rarely need intervention	
vertebral anomalies are rarely symptomatic	
no specific therapy is currently available for alexander disease	
neuroblastoma and ganglioneuroblastoma	
aortic stenosis may necessitate valve replacement	
treatment is limited to symptom management and supportive care	
alpers-huttenlocher syndrome	C0205710//Alpers Syndrome (disorder)//MTH
family education is critical	
supportive therapies	
hepatic	C0205054//Hepatic//MTH
treatment with cpap or bipap as indicated is appropriate	
seizure control is a goal of treatment	
other phenotypes	
gastrostomy may be required to provide adequate nutrition	
surgery for ptosis may provide symptomatic relief for some	
, influenza and pneumococcal)	
controls	
recommend intravenous aat augmentation therapy for individuals with established emphysema	
, fev1 35%-60% predicted)	
2 months post-liver transplant and not achieving statistical significance	
panniculitis	C0030326//Panniculitis//MTH
hypertensive individuals should receive appropriate management	
male relative without hematuria	
male relative with hematuria	
female relative without hematuria	
female relative with hematuria (i	
, heterozygous female)	
cochlear	C0009195//Cochlear structure//MTH
hearing aids should be prescribed when appropriate	
some individuals develop cataracts that interfere with vision	
these should be extracted when necessary	
diffuse leiomyomatosis	C4024984//Diffuse leiomyomatosis//HPO
symptomatic leiomyomas may require surgical intervention	
monitoring for and treatment of lymphoproliferation and hypersplenism	
however, sirolimus is not without side effects	
treatment of lymphoma is according to conventional protocols	
treatment of cytopenias and other autoimmune diseases	
caregiver and patient support groups are valuable	
options include:	
ssris	C0360105//Selective Serotonin Reuptake Inhibitors//MTH	C1579361//Serotonin and Norepinephrine Reuptake Inhibitors (SNRIs)//MTH
venlafaxine	C0078569//venlafaxine//MTH
however, weakness and lethargy are common side effects	
low-tech (e	
, alphabet board) and high-tech (i	
no therapy exists to prevent the progressive organ involvement	
rod-cone dystrophy	C0035334//Retinitis Pigmentosa//MTH
progressive sensorineural hearing loss	
hearing can be maximized with bilateral digital hearing aids	
exercise	C0015259//Exercise//MTH	C1522704//Exercise Pain Management//MTH
and metformin	
hypertriglyceridemia	C0020557//Hypertriglyceridemia//MTH	C0428478//Serum triglycerides raised//MTH	C1522137//Hypertriglyceridemia result//MTH
pancreatitis should be treated as in the general population	
urologic	C0042077//Urology//MTH
prevention of primary complications	
depression and seizures should be treated with appropriate medications	
the first such drug was tacrine	
however, this agent is also hepatotoxic	
antidepressant medication may improve associated depression	
seizures have occurred in some affected infants	
assignment of sex of rearing	
even in cais this may not always be easy	
cais	C0936016//Testicular Feminization//MTH
however, the issue of gonadectomy is controversial	
pais with predominantly female genitalia (incomplete ais)	
pais with ambiguous genitalia or predominantly male genitalia	
gynecomastia that develops in puberty eventually requires reduction mammoplasty	
mais	C0010028//Zea mays//MTH	C1138842//Maize//MTH
the customary medical treatment (i	
sometimes fundoplication as required	
no one drug has proven superior	
medications used for minor motor seizures (e	
hypermotoric behaviors are typically resistant to behavioral therapies	
unstable or nonambulatory children may benefit from physical therapy	
individualization and flexibility in the school are important educational strategies	
administration of 0	
strabismus may require surgical correction	
aniridia	C0003076//Aniridia//MTH
simple measures are often the most important:	
regular eye examinations and correction of refractive errors	
occlusion therapy for anisometropic amblyopia or strabismic amblyopia in childhood	
advice and help with schooling	
social support	C0037438//Social support//MTH	C0748877//Support System//MTH	C1540833//Social support (regime/therapy)//MTH	C1765341//Social support for caregiving//MTH	C3669642//Social Support - counseling strategy//MTH
lens	C0023317//Lens, Crystalline//MTH	C0023318//Lens (device)//MTH	C0996842//Genus Lens//MTH	C1449811//Lens Plant//MSH	C1509844//Lens device//MTH	C2239142//examination of lens//MTH	C3887646//Lens Device Component//MTH
children rarely require surgery (lens aspiration or lensectomy)	
in adults, phacoemulsification can be successful	
intraocular pressure	C0021888//Physiologic Intraocular Pressure//MTH	C0430888//Intraocular pressure test//MTH	C0578862//Intraocular pressure finding//MTH	C0595921//Intraocular pressure disorder//MTH
glaucoma is usually initially treated with topical anti-glaucoma medication	
trabeculectomy with or without antimetabolites (e	
medical treatment is generally ineffective and surgery is required	
cornea	C0010031//Cornea//MTH	C0010034//Corneal Diseases//MTH	C1550625//SpecimenType - Cornea//MTH
aniridic fibrosis syndrome	
wilms tumor	C0027708//Nephroblastoma//MTH	C0950121//Denys-Drash Syndrome//MTH	C3538905//NCI CTEP SDC Wilms Tumor Sub-Category Terminology//MTH
see wilms tumor overview	
the need for orthoses or other assistive devices varies individually	
most patients remain ambulatory without assistance for decades	
provide palliative care for the viable newborn	
educational support (e	
, behavioralists) who can provide the following:	
gait safety devices including canes and wheel chairs	
behavioral modification and cognitive aids as needed	
there are no formal management guidelines for apoe p	
leu167del-related lipid disorders	
in patients with fasting triglyceride levels:	
splenomegaly	C0038002//Splenomegaly//MSH
splenectomy should be avoided as it may worsen hyperlipidemia	
liver function abnormalities	
persistent nausea	C0746782//Persistent nausea//NANDA-I
vomiting	C0042963//Vomiting//MTH	C1963281//Vomiting Adverse Event//MTH	C3898969//Have Been Vomiting//MTH	C4084766//How Much Distress Vomiting//MTH	C4084767//Bothered by Vomiting//MTH	C4084768//Usual Severity Vomiting//MTH	C4084769//How Often Vomiting//MTH
abdominal pain	C0000737//Abdominal Pain//MTH
yellow discoloration of the skin	
bruising	C0009938//Contusions//MTH	C2136686//reported bruising (history)//MTH
any new petechial rash	
allopurinol	C0002144//Allopurinol//MSH
febuxostat	C0249529//febuxostat//MTH
treatment of esrd	
kidney transplantation	C0022671//Kidney Transplantation//MTH
arginine supplementation is obviously contraindicated	
rapidly reducing plasma ammonia concentration	
pharmacologic management to allow alternative pathway excretion of excess nitrogen	
in early treatment, feeding 1	
0 to 1	
older children require and tolerate lower protein intake	
seizures are easily treated by phenobarbital or carbamazepine	
discontinuing oral protein intake	
intravenous nitrogen scavenging therapy	
ammonia levels usually normalize with therapy	
nitrogen scavenging therapy needs to be continued during hemodialysis	
curative therapy is not available	
clinical history studies are limited	
aneurysms and focal stenoses are amenable to surgical intervention	
hernias may recur after surgical repair	
emphysema is treated symptomatically	
, swimming) performed in moderation	
no treatment is available	
see hereditary ataxias, management	
beta blockers are considered first line therapy	
however, individual responses to specific medications (e	
(see also therapies under investigation	
speech therapy may benefit persons with dysarthria	
one of the following vitamin e preparations is used:	
the naturally occurring form, rrr-α-tocopherol	
thalassemia major	C0002875//Cooley's anemia//MTH
transfusions are usually given every two to three weeks	
thalassemia intermedia	C0271979//Thalassemia Intermedia//MSH
cord blood transplantation	C0935850//umbilical cord blood transplantation//PDQ
uveal melanoma	C0220633//Uveal melanoma//MSH
malignant mesothelioma	C0345967//Malignant mesothelioma//MTH
thus, a cure is unlikely	
there is no specific treatment of bwcff syndrome	
symptomatic management involves the following	
ptosis may require surgical treatment	
hearing loss may require routine care including hearing aids	
epilepsy is treated using standard protocols	
management of heart failure	
management of neutropenia	
78 ± 0	
45-12	
8 years, with an average exposure of 7	
3 years	
educational support in school	
, renal or hepatic dysfunction)	
indicators are functional interference and poorly fitting footwear	
dental extractions are appropriate as required for dental crowding	
insertion of grommets is commonplace	
manifestations should be treated by specialists (e	
keratocysts usually require surgical excision	
systemic treatment with retinoids (e	
bethlem myopathy	C1834674//Bethlem myopathy//MSH
ullrich cmd	
contractures tend to be aggressive and may require surgery	
kcnq2-bfne	
refractory seizures are uncommon in kcnq2-related bfne	
kcnq2-nee	
augmentative communication techniques can be valuable for many patients	
antiepileptic treatment for seizures	
symptomatic treatment for headaches	
biotin and thiamine therapy	
biotin and thiamine need to be given lifelong	
in the acute stage empiric treatment with antimicrobial/antiviral agents	
fever control	
antiepileptic drugs for effective control of seizures	
symptomatic treatment of dystonia, including administration of l-dopa	
rehabilitation, physiotherapy, occupational therapy, and speech therapy	
educational programs adapted to individual needs	
therefore, renal tumors greater than 3	
no treatment for bcd currently exists	
psychosocial	C0542298//Psychosocial//MTH	C1458132//Treatment/Psychosocial Effects//MTH
milunsky et al [2011] provided management guidelines	
see table iii)	
they should not be cauterized	
most larger skin defects require surgical excision	
recommended treatment:	
second branchial arch anomalies	
excise branchial cleft cysts/fistulae	
otologic anomalies	
fit with appropriate aural habilitation as indicated	
enroll in an appropriate educational program for the hearing impaired	
consider canaloplasty to correct an atretic canal	
treat urologic and renal abnormalities in the standard manner	
if renal anomalies (e	
if esrd develops, consider renal transplantation	
global developmental disability/intellectual disability	
disordered sleep	
ophthalmologic findings	
eye findings are treated in a routine manner	
regular pulmonary hygiene to manage risk for pulmonary complications	
tracheostomy as indicated when secretions are difficult to manage	
eyelid surgery	
timing of eyelid surgery is controversial	
however, it remains controversial	
hormone replacement therapy (hrt)	C0282402//Hormone replacement therapy//MTH
it is important to:	
controversy exists regarding the treatment of asymptomatic individuals	
treatment of craniofacial manifestations (e	
there are no reports on the use of aflibercept	
the cnv regressed and the subretinal hemorrhage resolved	
genetic counseling and occupational counseling should be offered	
abdominal wall repair for omphalocele soon after birth	
generally, this surgery is well tolerated	
management of difficulties arising from macroglossia:	
some children benefit from tongue reduction surgery	
orthodontic intervention as needed in later childhood/adolescence	
assessment of speech difficulties	
management of cleft palate following standard protocols	
referral to a craniofacial surgeon if facial hemihyperplasia is significant	
treatment of neoplasias following standard pediatric oncology protocols	
, nephrocalcinosis)	
management of cardiac problems following standard protocols	
during acute episodes	
restrict protein intake if plasma ammonia is elevated	
without carglumic acid, hyperammonemia persisted longer (i	
, an additional 1-2 days)	
there is no treatment of proven efficacy for cadasil	
classic 21-ohd cah	
glucocorticoid replacement therapy	
the use of oral hydrocortisone suspension is discouraged	
during periods of stress (e	
affected individuals should carry medical information regarding emergency steroid dosing	
mineralocorticoid replacement therapy	
sodium chloride supplementation may not be necessary after infancy	
feminizing genitoplasty	
the systematic evidence for this belief is lacking	
testicular adrenal rest tumors	
transition from adolescence to adulthood	
women with classic cah had increased diastolic blood pressure	
subjective health status was significantly impaired and fertility compromised	
adrenalectomy	C0001632//Adrenalectomy//MSH
non-classic 21-ohd cah	
most survivors with cd require orthopedic care	
club feet require surgical correction	
the hips should be checked for luxation	
bracing is usually not helpful	
neonatal/infantile canavan disease	
seizures may be treated with antiepileptic drugs (aeds)	
diamox® seems to reduce intracranial pressure	
botox® injections may be used to relieve spasticity	
mild/juvenile canavan disease	
scoliosis may require bracing or surgical correction	
personality change may require antipsychotic medication	
a wig or hairpiece may be helpful for alopecia	
the following interventions are routine:	
cardiac myxoma	C0262929//Myxoma of the Endocardium//MTH	C1960546//Myxoma of heart//MTH
open-heart surgery	
cutaneous and mammary myxoma	
surgical excision	C0728940//Excision//MTH
cushing syndrome	C0010481//Cushing Syndrome//MTH	C0342443//Adrenal Cushing's syndrome//MTH	C4025651//Increased circulating cortisol level//MTH
bilateral adrenalectomy	C0193704//Bilateral adrenalectomy//SNOMEDCT_US
pituitary adenoma	C0032000//Pituitary Adenoma//MTH
transsphenoidal surgery	C2985562//Transsphenoidal Surgery//NCI
thyroid adenomas	C0151468//Thyroid Gland Follicular Adenoma//MTH
surgery if cancerous	
lccsct	
pms	C0018064//Equine Gonadotropins//MTH	C0033046//Premenstrual syndrome//MTH	C1418866//PRB1 gene//MTH	C1868117//POLYDACTYLY, POSTAXIAL, WITH PROGRESSIVE MYOPIA//MTH
surgery to remove primary and/or metastatic lesions	
no specific treatment is currently available for caveolinopathies	
management should include the following:	
infants are started with daily 1	
0 mg intramuscular or subcutaneous injections	
acute metabolic decompensation	C2673978//Acute metabolic decompensation//OMIM
long-term management	
these are accomplished by:	
parenteral ohcbl	
0 mg (~0	
betaine	C0005304//Betaine//MSH
optimal dosing and monitoring have not been adequately established	
folate and folinic acid	
the adult dose of folate is 1	
5 mg for maintenance	
dietary management	C0012159//Diet therapy//MTH	C0012160//nutritional management//MTH
other therapeutic considerations that have not been fully validated:	
methionine supplementation	
pyridoxine	C0034272//pyridoxine//MTH	C0202251//Vitamin B6 measurement//MTH	C3714638//Pyridoxine Drug Class//MTH
levocarnitine	C0087163//Levocarnitine//MTH
indicated for low plasma carnitine levels	
supportive therapy includes the following as needed:	
treatment of headache	
guidance for visual impairment	
classic cca	
this type of therapy is best instituted in childhood	
surgical release of contractures may be necessary	
consultation with an orthopedist is encouraged	
severe/lethal cca	
no general recommendations exist	
speech therapy may be required during periods of dental treatment	
sinus and middle ear infections require aggressive and timely treatment	
helmets may be advised for high-risk activities	
the treatment of cataracts is surgical	
regular rehabilitation can prevent or postpone osteoporosis	
recurrent hemorrhage or mass effect	
neuropsychological testing may be considered prior to any neurosurgical procedure	
microsurgical techniques rely on intraoperative examination for precise localization	
headaches	C0018681//Headache//MTH
neurologic deficits	C0521654//Neurologic Deficits//MSH
hypotonia and weakness	
patients may benefit from physical therapy	
scoliosis and joint contractures	
patients with more severe symptoms may require respiratory support	
peginterferon-α2b has also been given once a week	
the mechanism behind this response is unknown	
splenectomy is of unproved value	
orthopedic issues—thorax shortening, scoliosis/kyphosis	
occasionally, surgical treatment of spinal curvature is warranted	
others may have a more refractory course	
renal issues	
immunologic status	
most individuals affected with cdgs have functional immune systems	
additional management issues of adults with cdg	
orthopedic issues — thorax shortening, scoliosis/kyphosis	
recently, therapy may start in the prenatal period	
postnatal treatment	
emphasis must be on preventing secondary lung injury	
it is unclear whether ecmo improves survival in cdh	
prenatal treatment	
surgical correction of intestinal malrotation if present	
alternative communicative methods (e	
standard treatment for hearing loss	
standard interventions for cardiac defects	
appropriate treatment for seizures	
antibiotic prophylaxis and follow up for vesicoureteral reflux	
orchiopexy if cryptorchidism is present	
standard intervention for bicornuate uterus, if present	
cervical spine stenosis may require decompression	
thoracic and lumbar spine (for scoliosis)	
l-carnitine supplementation	
l-carnitine supplementation has relatively few side effects:	
hypoglycemic episodes are treated with intravenous dextrose infusion	
cardiomyopathy requires management by specialists in cardiology	
correction of polydactyly (optional)	
orthopedic care as required (e	
, for hip dysplasia)	
dental care	C0011331//Dental Procedures//MTH
standard treatment for renal and liver abnormalities	
pneumonia should be treated with antibiotics	
asthma can be treated with steroids	
standard treatment for cardiac abnormalities	
no consensus management guidelines have been developed to date	
improving gait, exercise tolerance, and flexion contractures	
unsuccessful steroid therapy was reported in one adult	
less symptomatic individuals can be started on 0	
0 mg/kg every other day	
higher-dose steroids may help with acute pain crises	
calcitonin	C0006668//Calcitonin//MTH	C0201924//Calcitonin measurement//MTH	C0770558//Human calcitonin//MTH	C1367551//CALCA gene//MTH	C1454696//CALCA protein, human//MTH	C1704385//Recombinant Calcitonin//MTH	C2825090//Calcitonin [EPC]//MTH	C3536753//Calcitonin preparation//MTH
losartan	C0126174//Losartan//MSH
pain in the tibia resolved completely following the surgery	
corticosteroids may delay skull hyperostosis and cranial nerve impingement	
three underwent internal auditory canal decompression with mixed results	
celiac disease	C0007570//Celiac Disease//MTH
a dietitian experienced in treating celiac disease should be involved	
, 100 mg) can damage the small intestine	
note that a slice of bread contains approximately 2	
5 grams of gluten	
some hidden sources of gluten:	
non-starchy foods such as soy sauce and beer	
, lipstick)	
refractory sprue or celiac disease	
cutaneous photosensitivity	C0349506//Photosensitivity of skin//MTH
reflectant sunscreens containing zinc oxide or titanium dioxide	
skin trauma should be avoided	
wound care is essential to prevent infection of opened blisters	
laser hair removal can be used to treat facial hypertrichosis	
topical antibiotics for corneal ulcers, scleritis, and blepharitis	
bone manifestations	
hemolytic anemia	C0002878//Anemia, Hemolytic//MSH
consider blood transfusions when hemolysis is significant	
cystic fibrosis (cf)	C0010674//Cystic Fibrosis//MTH
inhaled dornase alfa in all individuals age ≥6 years	
inhaled hypertonic saline in all individuals age ≥6 years	
recommended sequence for inhaled medications:	
an aerosolized antibiotic	
gly551asp and other specific pathogenic variants	
phe508del	
lung or heart/lung transplantation	
an option for some individuals with severe disease	
oral pancreatic enzyme replacement with meals	
congenital absence of the vas deferens (cavd)	
prevention of primary manifestations – cystic fibrosis	
aerosolized antibiotic	
all routine immunizations should be given at the recommended times	
pancreatic enzyme replacement and supplementation of fat-soluble vitamins	
high-calorie, high-fat nutritional supplements	
consultation with a nutritionist specializing in cf	
surveillance – cystic fibrosis	
culture respiratory tract secretions at least four times yearly	
75 g/kg, or 75 g maximum	
evaluate bone mineral density in adolescence	
agents/circumstances to avoid – cystic fibrosis	
avoid the following:	
respiratory irritants (e	
, smoke, dust)	
individuals with respiratory infections	
dehydration	C0011175//Dehydration//MTH	C1963090//Dehydration Adverse Event//MTH	C4284399//Dehydration procedure//MTH
increasing caloric intake may be of benefit	
constipation affects the majority of individuals	
seizures are treated as in the general population	
recurrent otitis media may require placement of pe tubes	
hyperkeratoses are treated as in the general population	
nonsurgical treatment of ophthalmologic findings:	
correction of ptosis	C0197280//Repair of blepharoptosis//SNOMEDCT_US
eye muscle surgery	C0197937//Eye muscle operation//MTH	C1705868//Strabismus surgery specialty//MTH
to correct or improve a compensatory head posture	
to improve ambulation and gross motor development in young children	
principles of surgical approach:	
profound weakening procedures (e	
orthodontic evaluation and appropriate intervention may be necessary	
treatment of colitis in cgd can be difficult	
corticosteroid treatment of heightened inflammatory response	
granulocyte infusions	
granulocyte infusions are generally well tolerated	
males with x-linked cgd	
, they are kell negative)	
kell-negative blood products are rarely available	
splints can be tried for foot drop	
choanal atresia	C0008297//Choanal Atresia//MSH
feeding/swallowing dysfunction	
renal evaluation	
renal ultrasound examination is recommended in all children	
endocrine evaluation	
coloboma	C0009363//Congenital ocular coloboma (disorder)//MTH
hearing loss should be assumed until proven otherwise	
communication	C0009452//Communication//MTH
deaf-blind service referral	
referral to deafblind education services (e	
frequent rest breaks may be needed	
myofacial release can improve posture and flexibility	
occasionally, sleep studies show obstructive apnea	
gi consultation is often indicated	
obsessive-compulsive disorder	C0028768//Obsessive-Compulsive Disorder//MTH
pervasive developmental disorder	C0524528//Pervasive Development Disorder//MTH	C0856975//Autistic behavior//MTH
sensory processing issues are likely implicated	
attention-deficit hyperactivity disorder	C1263846//Attention deficit hyperactivity disorder//MTH
understanding this is critical to devising appropriate interventional strategies	
general	C0205246//Generalized//MTH	C3812897//General medical service//MTH	C3891294//Safety Reporting Documentation//MTH
adequate nutrition and weight maintenance are essential	
appropriate bracing and stretching can minimize contractures	
mitochondrial myopathy	C0162670//Mitochondrial Myopathies//MTH
assistance with ambulation and posture	
surgical correction of ptosis as needed	
amyotrophic lateral sclerosis	C0002736//Amyotrophic Lateral Sclerosis//MTH
(als)	
frontotemporal dementia (ftd)	
spinal motor neuronopathy	
seizures should be managed by an experienced pediatric neurologist	
hematologic and immunologic defects	
select individuals may also receive intrathecal methotrexate and prednisilone	
once remission occurs, prompt hsct is recommended	
correction of refractive errors may improve visual acuity	
skin hypopigmentation	C0162835//Hypopigmentation disorder//MTH
skin protection varies depending on the degree of hypopigmentation	
neurologic abnormalities	C0497552//Congenital neurologic anomalies//MTH
skeletal dysplasia	C0029422//Osteochondrodysplasias//MTH	C0410528//Skeletal dysplasia//MTH
orthopedic surgery may be complicated by low bone density	
immunodeficiency and infection	
nutrition and ocular health have become increasingly topical:	
preparedness for appropriate countermeasures (e	
an apnea monitor is recommended	
anticonvulsants may be required	
surgical instrumentation or prolonged	
bracing may be required to correct a progressive thoracolumbar scoliosis	
paradoxical sweating	C4479124//Paradoxical sweating//OMIM
treatment should be reserved for adults and older children	
clonidine	C0009014//Clonidine//MSH
oral clonidine, at starting doses of 0	
05 mg to 0	
1 mg four times daily may be required	
abrupt cessation of clonidine can lead to prominent hypertension	
moxonidine was well tolerated in the short term	
however, long-term observations are not yet available	
niccd	C1853942//CITRULLINEMIA, TYPE II, NEONATAL-ONSET//MTH
the treatment with therapeutic formulas is not lifelong	
fttdcd	
ctln2	C1863844//Adult-onset citrullinemia type 2//MTH
other treatments include the following:	
saheki et al 2010	
yazaki et al 2010	
ohura et al, personal communication	
okano et al, personal communication]	
aro	C0019952//Anesthesia-Resuscitation Department, Hospital//MSH	C1366496//CYP19A1 gene//MTH	C1705771//CYP19A1 wt Allele//MTH
adoii	
orthopedic treatment is often required for fractures and arthritis	
no specific dietary or other metabolic treatment is available	
a trial of antiepileptic drugs (aeds) (e	
treatment of behavioral problems is standard and requires periodic reassessment	
no definitive treatments exist for the congenital muscular dystrophies	
speech therapy may be indicated	
close attention to oral hygiene is indicated	
medical treatment	
acetylcholineesterase (ache) inhibitors (pyridostigmine)	
3,4-diaminopyridine (3,4-dap)	
quinidine, fluoxetine	
however, it may induce suicidal ideation	
non-medical treatment	
orthotics or a wheelchair	
a percutaneous gastric tube	
exercise within the affected individual's capability	
note: (1) fatigue may improve with exercise	
wheelchair for mobility because of gait instability	
lower urinary tract involvement [krhut et al 2014]	
vocal cord paresis	C0751576//Partial Paralysis (Paresis) Vocal Cords//MSH
treatment may include:	
ankle/foot orthoses	
forearm crutches or canes	
rarely, wheelchairs	
career and employment counseling	
anticipatory counseling is appropriate	
forearm crutches or canes for gait stability for some individuals	
many remain physically active	
the following may be indicated:	
wheelchairs for mobility because of gait instability	
for treatment of findings common to all	
trpv4-associated disorders	
pain and depression	
neuropathy	C0442874//Neuropathy//MTH
vocal cord involvement	
respiratory therapy/support (e	
, bipap)	
physical therapy/exercise to maintain as much function as possible	
orthopedic evaluation with consideration of surgical intervention (i	
patients undergoing surgical fusion typically do well	
appropriate treatment includes:	
prosthetic and adaptive devices for weak hands	
ankle/foot orthoses to correct foot drop and aid walking	
fewer than 5% of affected individuals need wheelchairs	
treatment of spinal deformities	
physiotherapy helps to preserve flexibility	
treatment of foot deformities	
physiotherapy to preserve flexibility	
treatment of pain and cramps	
, pregabalin, gabapentin)	
cramps can be controlled with quinine	
some need wheelchairs	
surgery to correct spine deformities	
wheelchairs as needed because of gait instability	
no specific treatment reverses the manifestations of cmt4j	
severely affected individuals need wheelchairs	
bipap for those with respiratory muscle weakness	
peripheral neuropathy	C0031117//Peripheral Neuropathy//MTH
see charcot-marie-tooth hereditary neuropathy overview, management	
individualized educational program for developmental delay	
feeding gastrostomy tube placement for failure to thrive	
management of hearing loss	
management of cataracts and other ophthalmologic complications	
use of sunscreens for cutaneous photosensitivity	
use of sunglasses for lens and retina protection	
spectacle correction of refractive errors	
psychosocial support for affected individuals and their families	
recurrent infections should be treated per standard therapy	
no specific support exists for individuals with col4a1-related disorders	
seizures are managed using standard protocols	
glaucoma is initially treated with topical anti-glaucoma medication	
coenzyme q10 supplementation	
coq4-related coenzyme q10 deficiency	
coq6-related coenzyme q10 deficiency	
homozygotes for the pathogenic variants p	
gly255arg or p	
ala353asp responded [heeringa et al 2011]	
coq8b-related coenzyme q10 deficiency	
pdss2-related coenzyme q10 deficiency	
coq8a-related coenzyme q10 deficiency	
coq9-related coenzyme q10 deficiency	
most infants require nasogastric or gastrostomy feeding	
pyloric stenosis is treated surgically	
anecdotally, affected children have very high caloric needs	
kyphoscoliosis may require surgical correction	
dental abnormalities should be addressed by a pediatric dentist	
papillomata	C0030354//Papilloma//MTH
thus, cortisol deficiency may also be considered	
malignant tumors	C0006826//Malignant Neoplasms//MTH
treatment of malignant tumors follows standard protocols	
info and ghr	
nlm	C0027470//National Library of Medicine (U.S.)//MTH
nih	C0027468//United States National Institutes of Health//MTH	C1513843//NIH Mouse//MTH
gov	C1419208//RAB3D gene//MTH
current treatment for long-chain fatty-acid oxidation disorders:	
avoid known triggers	
treatment consists primarily of surgical intervention	
cytokine administration may shorten the consolidation period	
timing of subsequent craniofacial surgeries influences their success	
limbs	C0015385//Limb structure//MTH
behavior therapy for behavior problems by developmental pediatrician	
seizure management with antiepileptic drugs by epilepsy specialist	
treatment of movement disorder by movement disorder specialist	
gamt deficiency	C0574080//Guanidinoacetate methyltransferase deficiency//MSH
treatment is as follows:	
4-0	
8g/kg/day)	
available databases (e	
treatment outcome of symptomatic individuals with gamt deficiency	
in 18% of individuals seizures were eliminated	
in 49% seizure frequency decreased	
improvement was seen in 60% of individuals	
treatment outcome of asymptomatic individuals with gamt deficiency	
agat deficiency	C2675179//Arginine:Glycine Amidinotransferase Deficiency//MTH
treatment outcome of symptomatic individuals with agat deficiency	
treatment outcome of asymptomatic individuals with agat deficiency	
crtr deficiency	
the goal of treatment is to replenish cerebral creatine levels	
treatment has included:	
glycine 150 mg/kg bw/day in 3 doses	
treatment outcome of individuals with crtr deficiency	
spectacles or contact lenses for correction of refractive errors	
management of strabismus	
penetrating keratoplasty	C0022592//Keratoplasty, Penetrating//MSH
most grafts remain clear after penetrating keratoplasty	
see acmg-act sheet, acmg algorithm	
acute management of hyperammonemia	
rapidly decreasing plasma ammonia concentration	
scavenger therapy should be continued while dialysis is being performed	
note: exchange transfusions have no place in hyperammonemic treatment	
0-1	
control of intracranial pressure	
cerebral edema and ischemia may be documented by mri	
chronic management	
protein restriction	
nitrogen scavenger therapy	
as children grow, doses change to 9	
9-13 g/m2/day of sodium phenylbutyrate and 8	
8-15	
4 g/m2/day of arginine	
the initial dosage for phenylbutyrate-naïve patients is 4	
5-11	
2 ml/m2/day (5-12	
4 g/m2/day)	
living related-donor liver transplantation	
renal fanconi syndrome	C0341703//Adult Fanconi syndrome//MTH
phosphate replacement to prevent and treat rickets	
renal glomerular disease	C0268731//Renal glomerular disease//MTH
renal transplantation	C0022671//Kidney Transplantation//MTH
73 m2 and azotemia and hypertension rapidly progress	
symptoms often determine the exact time of transplantation	
retinal involvement is irreversible	
nutrition must be adequate for growth	
oral l-thyroxine replacement for hypothyroidism	
insulin for diabetes mellitus	
speech therapy and physical therapy	
standard treatment for benign intracranial hypertension	
other central nervous system complications are irreversible	
chenodeoxycholic acid (cdca)	
normalization of nerve conduction velocities and subsequent stabilization	
cdca treatment may be more useful when started early	
luyckx et al 2014]	
coenzyme q10 (coq10) treatment may improve muscle weakness	
repair of inguinal hernia(s)	
routine management of hip dislocation	
routine management of refractive errors	
antiepileptic drugs (aeds): valproate	
or a combination of aeds can be used	
psychological help as needed for self-image issues	
recommended drugs are nadolol (1-2	
flecainide	C0016229//Flecainide//MSH
however, urinary ne excretion exceeds normal levels	
fludrocortisone, at dosages of 0	
ptosis can be corrected by surgery	
sinus problems should be treated as needed	
dilated cardiomyopathy	C0007193//Cardiomyopathy, Dilated//MTH	C2984282//Dilated Cardiomyopathy Pathway//MTH
mean lvef increased from 36% to 53%	
measurement of reduced sphericity indicated improved ventricular geometry	
scoliosis treatment as needed is appropriate	
corticosteroid therapy	C0149783//Steroid therapy//MTH
prednisone	C0032952//Prednisone//MTH
75 mg/kg/day or 1	
5 and 0	
6 mg/kg/day [fenichel et al 1991]	
follow-up studies showed that a dose of 0	
3 mg/kg/day [fenichel et al 1991]	
35 mg/kg/day) in both dmd and bmd	
4 mg/kg/day	
at lower doses of 0	
alternate-day dosing and intermittent dosing (e	
side effects did not negatively affect quality of life	
initiation and length of treatment	
75 mg/kg/day, prednisone 0	
published guidelines	
the optimal maintenance dose of prednisone (0	
3 mg/kg/day	
5 mg/kg/day	
3 mg/kg/day after three to four months	
deflazacort (0	
bmd	C0005938//Bone Density//MTH	C0177804//Bone Mineral Density Test//MTH	C0339510//Vitelliform Macular Dystrophy//MTH	C0917713//Becker Muscular Dystrophy//MTH	C1414083//DMD gene//MTH	C1826421//BEST1 gene//MTH	C2699549//DMD wt Allele//MTH
elements of the guidelines include the following:	
consider therapy based on cardiac phenotype (i	
, dcm or arrhythmia)	
cardiac conduction system disease and arrhythmias	
, atrial or atrioventricular node ablations)	
lmna-related dcm	
symptomatic dcm represents late disease	
individuals with idiopathic or familial dilated cardiomyopathy should:	
epileptic seizures require antiepileptic drugs (aeds)	
special adaptive chairs or positioners may be required	
educational	
spectacle correction is appropriate where indicated	
manifestations of the 16p11	
early diagnosis and provision of therapies facilitate the best outcome	
referral to other appropriate medical specialists (sue	
neurodevelopmental disabilities including asd	
obesity and overweight	
maintain an active lifestyle	
chiari i malformation or syringomyelia	
the spasms are responsive to acth	
special feeding techniques or devices, e	
structural anomalies (e	
hypothyroidism is treated in a standard manner	
no guidelines have been established for treatment of dent disease	
thiazide diuretics in doses greater than 0	
however, their effectiveness has not been clear	
the response to antiepileptic drugs (aeds) is variable	
routine ophthalmologic management of strabismus, if present	
routine correction of refractive error	
see hereditary deafness and hearing loss overview for details	
hearing habilitation	
for those with nonsyndromic bilateral congenital hearing loss	
hearing aids should be fitted as soon as possible	
educational programs designed for individuals with hearing impairment are appropriate	
see deafness and hereditary hearing loss overview	
management of neurologic manifestations in neonatal multisystem disease	
hypotonia may be significant	
the one-year survival rate was 64%	
five of the 14 survived longer than five years	
corticosteroid administration	
corticosteroids may be slowly tapered to the minimal effective dose	
the recommended maximum maintenance dose is ≤0	
red blood cell transfusion	C0086252//Red Blood Cell Transfusion//MTH
7% ±10	
1% ±11	
survival was the best (92	
cancer treatment	C0920425//cancer treatment//MEDCIN
treatment of malignancies should be coordinated by an oncologist	
, for clubfeet)	
comprehensive coordinated care among specialties is required	
bone marrow failure (bmf)	
, aggression, mood swings)	
the suggested starting dose of oxymetholone is 0	
hematopoietic growth factors may be useful in bmf	
this risk has not been quantitated	
studies are ongoing	
dld pathogenic variants cause variable deficiency in three enzymatic pathways	
branched chain alpha-ketoacid dehydrogenase (bckdh) complex	
α-ketoglutarate dehydrogenase (αkgdh) complex	
pyruvate dehydrogenase (pdh) complex	
early-onset neurologic presentation	
review of treatment strategies	
protein/bcaa-restriction	
ketogenic/high-fat diet	
five had no clinical or biochemical benefit	
two improved clinically	
carbohydrate tolerance	
dichloroacetate (dca)	
additional therapies used with limited success include:	
coenzyme q10	C0056077//coenzyme Q10//MTH
lipoic acid	C0023791//Thioctic Acid//MSH
biotin	C0005575//Biotin//MTH	C2700256//Vitamin B7 Measurement//MTH
empiric recommendations	
for acute management (based on the above review)	
this is typically achieved by the following:	
promotion of an anabolic state:	
maintain serum glucose concentration in the normal range	
protein should then be reintroduced gradually	
hepatic presentation	
correction of metabolic acidosis with sodium bicarbonate	
correction of any coagulopathy with fresh frozen plasma	
avoidance of liver-toxic medications	
episodes of catabolic stress (e	
caution:	
high doses are usually required (0	
4-1	
0 mg/kg/day of glibenclamide)	
transfer protocols are available at www	
diabetesgenes	
org	C1522486//Professional Organization or Group//MTH
high caloric intake should be maintained to achieve weight gain	
insulin can be discontinued when blood glucose concentrations stabilize	
, some residual endogenous insulin remains)	
note: macroglossia could potentially cause airway obstruction	
currently no effective treatment exists for any type of hsan	
provision of corrective lenses for myopia	
treatment of retinal detachments or glaucoma	
antiepileptic drugs for seizures	
children	C0008059//Child//MTH	C0680063//Offspring//MTH
adults	C0001675//Adult//MTH
gradual increase to higher doses is recommended	
for affected children, adaptation of educational programming to abilities	
duane anomaly	C0013261//Duane Retraction Syndrome//MTH
severe strabismus may require eye surgery	
radial ray malformations	
hearing deficits	
hearing aids may be required	
nonsurgical treatment of ophthalmologic findings	
surgical treatment of ophthalmologic findings (extraocular muscle surgery)	
to correct or improve compensatory head posture	
to improve upshoot or downshoot	
principles of surgical approach as reviewed in	
kekunnaya et al [2015]	
type 1 and type 3	
type 2	C0441730//Type 2//MTH	C4085652//Bristol Stool Type 2//MTH
approach for non-treatment	
approach for treatment	
the galactose challenge	
for example:	
, after the introduction of solid foods)	
supportive care may include the following:	
occupational and physical therapy	
alternative and augmentative communication	
behavioral therapy (e	
, applied behavioral analysis therapy)	
psychotropic medications for behavioral manifestations	
many of these are preventable	
seizures should be managed by a neurologist using standard practice	
childhood apraxia of speech	C0750927//Apraxia, Developmental Verbal//MTH
anxiety/selective mutism	
autism spectrum disorder (asd)	
attention deficit hyperactivity disorder (adhd)	C1263846//Attention deficit hyperactivity disorder//MTH	C4049909//Attention Deficit Hyperactivity Disorder (ADHD) Survey//MTH
aggression	C0001807//Aggressive behavior//MTH	C1457883//Aggressive reaction//MTH	C4050402//Aggression Scale (BASC-2)//MTH
applied behavior analysis intervention is recommended	
oppositionality	C2013199//oppositional behavior//MEDCIN
specific medical problems are treated in the following ways:	
hydrocephalus as needed with ventriculo-peritoneal shunting	
aortic dilation with beta blocker therapy in some affected individuals	
strabismus in the usual manner	
recurrent otitis media in the usual manner	
poor feeding in infants	
human growth hormone replacement therapy	
club feet	C0009081//Congenital clubfoot//MTH
casting	
educational program should be tailored to individual needs	
educational programs to address the specific needs identified	
speech therapy directed at improving communication skills	
therapeutic management of sleep disturbances if necessary	
early intervention with occupational therapy for feeding problems	
consideration of tube feeding for severe persisting feeding problems	
anticholinergics (e	
, trihexyphenidyl)	
if medications fail	
, prior to sufficient medication trials)	
acetazolamide	C0000981//Acetazolamide//MTH
sulthiame 50-200 mg daily may reduce the attack rate	
this medication is generally well tolerated	
surgical intervention is required to correct pyloric atresia	
many children need medical treatment for gastroesophageal reflux disease	
primary layers may include any the following:	
ordinary band-aids®	
non-stick products (e	
, telfa® or n-terface®)	
, mepitel® or mepilex®)	
other nutritional deficiencies must also be addressed:	
calcium and vitamin d supplementation for osteopenia and osteoporosis	
selenium and carnitine replacement to help prevent dilated cardiomyopathy	
zinc replacement to enhance wound healing	
occupational therapy may be helpful in preventing progressive hand contractures	
psychosocial support including social services and psychological counseling is essential	
ordinaryband-aids®	
the most common secondary complication is infection	
both antibiotics and antiseptics need to be employed	
dressings usually involve three layers:	
some individuals with ebs can use ordinary bandages	
foam dressings and/or rolls of gauze (e	
, one-layer) dressing	
dystrophic nails	C0221260//Dystrophia unguium//MTH
in many cases, wigs are helpful	
palmoplantar hyperkeratosis	C0022596//Palmoplantar Keratosis//MTH
skin emollients may help relieve palmoplantar hyperkeratosis	
however, pain can be difficult to control	
career counseling is recommended	
deep stitches should be applied generously	
anti-inflammatory drugs may help with joint pain	
cardiovascular problems should be treated in a standard manner	
modalities must be tailored to the individual	
assistive devices	C0036605//Self-Help Devices//MSH
braces are useful to improve joint stability	
pain medication	C0002771//Analgesics//MTH
adjustments may be necessary for other populations	
nsaids (nonsteroidal anti-inflammatory drugs) (e	
cox-2 inhibitors (e	
they are also sometimes helpful in treating neuropathic pain	
all require gradual titration before reaching therapeutic levels	
topiramate and lamotrigine have also been used successfully	
nausea is the most common side effect	
routine use of benzodiazepines is not recommended	
medication precautions	
abrupt cessation of anti-seizure medications can precipitate a seizure	
when discontinuing, they should be tapered gradually	
severity can range from mild to life threatening	
surgery and other procedures	
anesthetic nerve blocks can provide temporary relief of neuropathic pain	
bone density	C0005938//Bone Density//MTH	C0177804//Bone Mineral Density Test//MTH
for severe bleeding (e	
other treatable causes, such as h	
pylori infection, should be investigated	
rarely, severe enlargement (>4	
5-5	
0 cm) requires surgical evaluation	
periodontal disease should be identified and treated	
temporomandibular joint laxity and dysfunction are difficult to treat	
there are no specific interventions of proven benefit	
intra-oral devices are sometimes helpful	
psychiatric	C0033873//Psychiatry Specialty//MTH	C0205487//Psychiatric//MTH	C1548428//Referral type - Psychiatric//MTH	C3526598//Psychiatric service//MTH
antidepressants are also of great benefit	
consumer support groups are available and can be very beneficial	
, the uterus in pregnancy)	
bracing may be required to support unstable joints	
swimming is recommended	
vascular surgery is fraught with danger	
antispastic medications	
muscle relaxants	C0358430//Muscle relaxants//MTH	C3540042//Muscle relaxants FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE//MTH
contractures	C0009917//Contracture//MTH
severe diarrhea	C1443924//Severe diarrhea//SNOMEDCT_US
maintain hydration & caloric intake	
tube feeding often necessary	
poor energy metabolism & oxidative stress	
, contractures)	
, feeding, grooming, dressing, writing)	
routine repair is appropriate	
pulmonary emphysema is treated symptomatically	
no definitive treatment is available	
based on experience in other related disorders (e	
aortic aneurysm replacement has been performed successfully	
joint hypermobility can be supported by muscle reinforcing physical therapy	
standard management of gastroesophageal reflux	
standard interventions for:	
cardiac defects	C0741916//Cardiac defects//OMIM
hip dysplasia and other skeletal complications	
cryptorchidism and/or micropenis	
refractive errors, strabismus, or other ophthalmologic issues	
seizures, if present	
then 1 mg 1x daily thereafter)	
prevnar-13® and h	
the incidence of post-splenectomy sepsis varies among studies	
cholecystectomy	C0008320//Cholecystectomy procedure//MTH
valproic acid is the first drug of choice	
it diminishes myoclonus and the frequency of generalized seizures	
the phototoxic pain is not responsive to narcotic analgesics	
tanning products	
β-carotene	
hepatic complications may be accompanied by motor neuropathy	
the pain is not responsive to narcotic analgesics	
sun creams containing a physical reflecting agent (e	
reports on treatments in a series involve heterogeneous populations	
cooling the extremities reduces pain in a symptomatic person	
01) [mork et al 2004]	
experts have reported typically mild to moderate pain relief	
remissions (i	
carbamazepine	C0006949//Carbamazepine//MTH	C3853625//Carbamazepine (assay)//MTH
oxcarbazepine use in treating em has not been reported	
topical application of 1	
0% amitriptyline hydrochloride and 0	
calcium antagonists	
magnesium	C0024467//Magnesium//MTH	C0373675//Magnesium measurement//MTH	C2348270//Dietary Magnesium//MTH	C3540792//Magnesium supplements//MTH	C3714621//Magnesium Drug Class//MTH
cyclosporine was successful in one person with erythromelalgia	
sympathetic block, surgical sympathectomy, and epidural infusion	
the main problems to manage are:	
adaptation of education to the level of cognitive handicap	
epilepsy, which is amendable to standard treatments	
osteochondromas require no therapy in the absence of clinical problems	
leg-length inequalities greater than 2	
surgical resection is the treatment for sarcomatous degeneration	
3% (±5	
9%) [mehta et al 2017]	
mds/aml treatment remains challenging	
solid tumors	C0280100//Solid tumour//MDR
acroparesthesia	C0234221//Acroparesthesia//MTH
diphenylhydantoin	C0031507//Phenytoin//MTH
a potential side effect of diphenylhydantoin is gingival hypertrophy	
carbamazepine has similar effects	
chronic hemodialysis and/or renal transplantation have become lifesaving procedures	
therefore, successful renal transplantation corrects renal function	
thrombosis	C0040053//Thrombosis//MTH	C0302148//Blood Clot//MTH	C2586211//Thrombosis of blood vessel//MTH
5 (therapeutic range 2	
colonic polyps	C0009376//Colonic Polyps//MTH	C2911243//Encounter due to family history of colonic polyps//MTH
types of colectomy include the following:	
total colectomy with ileorectal anastomosis (ira)	
this is a single-stage procedure	
total proctocolectomy with permanent ileostomy	
the choice of procedure depends on the clinical circumstances	
small-bowel polyps	
osteomas may be removed for cosmetic reasons	
desmoid tumors	C0079218//Fibromatosis, Aggressive//MSH
adrenal tumors	C0001624//Adrenal Gland Neoplasms//MTH
chemoprevention	C0278925//chemoprevention of cancer//MTH	C0282515//Chemoprevention//MTH
nsaids	C0003211//Anti-Inflammatory Agents, Non-Steroidal//MTH
appropriate treatment for:	
inguinal hernias	C0019294//Hernia, Inguinal//MSH
routine repair	
cutis laxa	C0010495//Cutis Laxa//MTH
pulmonary emphysema	C0034067//Pulmonary Emphysema//MTH
no treatment available	
no definite treatment is available to date	
inadequate nutrition	C4062955//Inadequate nutrition//NANDA-I
standard treatment w/antiepileptic drugs	
immobility/wheelchair dependence	
, wheelchair	
cardiomyopathy and arrhythmia	
standard treatment per cardiology recommendations	
consider granulocyte colony stimulating factor 2	
significant acidosis	
consider bicarbonate therapy	
cataract and/or strabismus	
surgical treatment if indicated	
hearing aids	C0018768//Hearing Aids//MSH
there is no definite treatment for fcmd	
monitoring for orthopedic complications such as foot deformity and scoliosis	
prompt treatment of acute respiratory tract infections	
antiepileptic drugs (aeds) when indicated	
surgical treatment for gastroesophageal reflux when indicated	
gastrostomy when indicated to assure adequate caloric intake	
routine therapy of cardiomyopathy	
feeding problems	C0232466//Feeding difficulties//MTH	C0699815//Feeding difficulties and mismanagement//MTH
maintain adequate nutrition and avoid aspiration	
gastroesophageal reflux	C0017168//Gastroesophageal reflux disease//MTH	C3813607//Infantile Gastroesophageal Reflux//MTH	C4317146//Acid reflux//MTH
orthostatic hypotension	C0020651//Hypotension, Orthostatic//MTH
counter-maneuvers (e	
squatting had the greatest effect	
kidney and bladder	
bradyarrhythmia	C0079035//Bradyarrhythmia (disorder)//MTH	C0428977//Bradycardia//MTH
soft contact lenses can promote corneal healing	
corneal transplantation has had limited success	
spinal fusion may be necessary	
many adults use walkers or wheelchairs when outside the home	
sialorrhea is a common	
surgical treatment of gastrointestinal atresia when present	
follow up and treatment of possible cardiac and renal anomalies	
treatment for significant hearing loss	
developmental or educational intervention for children with learning difficulties	
retinal avascularity per se often requires no treatment	
individualized management of behavior problems	
neurologic management of seizures	
standard management of chronic constipation for individuals with fgs1	
communication rehabilitation with sign languages or alternative means of communication	
standard treatment for any of the following if identified:	
refractive errors and strabismus	
orthopedic complications	
investigation for celiac disease if indicated by clinical features	
cervical spine instability	C0410652//Cervical spine instability//MTH
large joint dislocations	C4025260//Large joint dislocations//HPO
scoliosis is treated medically	
no effective surgical intervention has been described	
club feet are managed in a routine manner	
febrile and inflammatory episodes are usually treated with nsaids	
papillomatosis	C0205875//Papillomatosis//MSH
camptodactyly often improves with physical and occupational therapy	
consultation with:	
folate formulations	
leucovorin is available in oral and parenteral formulations	
neither drug is available for parenteral administration	
deplin® is available as a 15-mg tablet	
folate dosing	
with intramuscular injections of approximately 1	
speech and language deficits	
no single recommended treatment exists	
dysarthria [pennington et al 2009]	
language deficits [law et al 2003]	
literacy impairments [snowling & hulme 2012]	
cognitive deficits	C0009241//Cognition Disorders//MTH	C0338656//Impaired cognition//MTH
fine and gross motor deficits	
fragile x syndrome	C0016667//Fragile X Syndrome//MTH
therapy must be individualized and closely monitored	
fxtas	C1839780//FRAGILE X TREMOR/ATAXIA SYNDROME//MTH
poi	C0443045//Poi serotype//MTH	C0542548//Personal Orientation Inventory//MTH
there is little objective evidence regarding management of frda	
speech therapy to maximize communication skills	
treatment of sleep apnea by continuous positive airway pressure	
measures include the following:	
in fryns syndrome, additional anomalies may dictate further consultations	
see also congenital diaphragmatic hernia overview	
physical therapy and rehabilitation	
consultation with a physical therapist is indicated	
exercise in fshd	
ophthalmologic disease	
orthopedic intervention	
there is no consensus treatment guideline for ftd3	
individuals with seizures are treated with antiepileptic drugs	
nutritional intervention (e	
wheelchairs can be useful for some individuals	
5x109/l can vary greatly among patients	
fevers and infections require prompt treatment with antibiotics	
treatment of arterial calcification	
bisphosphonate therapy	C4510264//Bisphosphonate therapy//SNOMEDCT_US
026, log-rank test)	
the dose of pamidronate has varied from 0	
cardiovascular treatment	
anti-hypertensive therapy	
017-0	
068 μg/kg/min [ciana et al 1997]	
prevention of coronary thrombosis	
treatment of hearing loss	
generalized epimerase deficiency galactosemia	
, some fruits and vegetables, organ meats)	
, hepatic cirrhosis or mature cataracts)	
peripheral epimerase deficiency galactosemia	
intermediate epimerase deficiency galactosemia	
however, insufficient data exist to make firm recommendations	
appropriate ophthalmologic treatment (e	
individuals with gata1-related cytopenia are treated supportively	
transfusion of blood products for severe anemia and bleeding	
analgesics for bone pain	
, improved joint range of motion)	
supplemental treatment	
care is best provided by a physician (e	
clobazam (0	
topiramate [coppola et al 2002]	
ethosuximide	C0015043//Ethosuximide//MTH	C0202381//Ethosuximide measurement//MTH
can be effective for absence seizures	
levetiracetam (20-80 mg/kg/day)	
potassium bromide	C0071754//potassium bromide//MSH
phenobarbital	C0031412//Phenobarbital//MTH	C0524238//Phenobarbital measurement//MTH
sleep deprivation and illness can exacerbate scn1a-related seizures	
routine seizure and personal safety counseling is indicated	
seizures are not always responsive to conventional aeds	
ethosuximide and high-dose piracetam for myoclonic seizures	
placement of an indwelling venous access device	
creating a portable microenvironment	
having a written emergency department protocol	
establishing emergency routines for the family	
creating personal time to decrease parent stress	
finding respite care	
contacting an internet support group	
joint manifestations: regular physiotherapy to prevent joint limitation	
heart: valve replacement	
tracheal stenosis: tracheostomy when severe	
surgical treatment	C0543467//Operative Surgical Procedures//MTH
pcg is almost always managed surgically	
beta-blockers (e	
, timolol), parasympathomimetics (e	
, pilocarpine), sympathomimetics (e	
treatment of refractive errors	
affected individuals develop a mild compensated metabolic acidosis when ketotic	
phenobarbital and valproic acid can inhibit glut1 transport	
valproic acid may partially inhibit beta-oxidation of fatty acids	
these agents also can cause kidney stones	
response has been modest at best	
gm1 gangliosidosis	C0085131//Gangliosidosis GM1//MTH
maintenance of adequate hydration and adequate calories for growth	
aggressive seizure control	
medical management of cardiac involvement	
mps ivb	C0086652//Mucopolysaccharidosis type IVB//MTH
the general concepts of care include the following	
sex assignment	
all individuals should receive a sex of rearing	
surgical intervention should focus on functionality	
removal of müllerian remnants may be considered	
management of gonads	
hormone therapy	C0279025//Hormone Therapy//MTH
if an individual is given a male sex assignment:	
5 standard deviations below the mean for age)	
testosterone therapy is typically required to initiate and sustain puberty	
if an individual is given a female sex assignment:	
estrogen therapy is used to initiate breast development and puberty	
psychosocial aspects of care	
” [lee et al 2006]	
later, educational and behavioral therapy are often warranted	
oral-motor therapy to alleviate chewing and swallowing problems	
routine protocols to alleviate sleep apnea	
tympanostomy tube placement for recurrent ear infections	
surgical removal of ingrown toenails to prevent infection	
walkers or other assistive walking devices	
intravenous fluids to prevent dehydration in individuals with recurrent vomiting	
surgical bone lengthening may be an option for some	
adaptive aids for people with short stature are appropriate	
speech/language deficits	
metabolic specialist familiar with the multisystem nature of gsdi	
medical nutrition therapy goals	
maintain	C0024501//Maintenance//MTH	C0721534//Maintain brand of benzocaine//MTH
normal glucose levels and prevent hypoglycemia:	
frequent daytime feedings	
note: recommendations for uncooked cornstarch dosing are: 1	
provide	C0359589//Provide (product)//MTH	C1999230//Providing (action)//MTH
optimal nutrition for growth and development:	
, protein low in fat)	
treatment of other manifestations	
sodium levels should also be monitored	
kidney transplantation can be performed for esrd	
liver transplantation can be considered when other interventions have failed	
g-csf should be administered subcutaneously starting at 1	
0 μg/kg given daily or every other day	
0 x 109/l is reached	
arteriopathy	C0852949//Arteriopathic disease//MTH
conduction disturbances	
muscle weakness	C0030552//Paresis//MTH	C0151786//Muscle Weakness//MTH
nutrition/feeding	
respiratory insufficiency	C0034088//Pulmonary Valve Insufficiency//MTH	C0035229//Respiratory Insufficiency//MTH	C1145670//Respiratory Failure//MTH
respiratory support including cpap and bipap may be required	
special formulas are not required	
3 mmol/l)	
emergency protocol	
5 normal saline administered at 1	
hepatic manifestations	
selecting appropriate candidates for liver transplantation can be complex	
aerobic training (on a regular diet)	
95% confidence intervals 20	
3 to 2496	
7) after controlling for age	
7 metabolic equivalents (mets, with 1met equaling 3	
5 ml o2/kg/min) necessary for independent living	
5mets higher than in those who were not active	
avoid a totally sedentary life, which induces deconditioning	
pharmacologic and nutritional treatments	
the authors' conclusions:	
this treatment does not influence sustained or unexpected exercise	
a carbohydrate-rich diet was of benefit	
pharmacologic treatments	
nutritional treatments	
liver phk deficiency	
hypoglycemia	C0020615//Hypoglycemia//MTH
the dose of cornstarch can range from 0	
6 to 2	
5 g/kg every six hours based on clinical symptoms	
for signs of	
muscle phk deficiency	
surgery may be required	
hypothalamic involvement	
central diabetes insipidus may require treatment with desmopressin	
temperature dysregulation can be managed by modifying the environment	
surgery of hand and foot defects can improve dexterity	
tethered cord may require surgical intervention	
some children may require a gastrostomy and/or tracheostomy	
acute attacks	
in an individual presenting with acute abdominal symptoms:	
discontinue all nonessential medications	
provide glucose-containing iv solution to reverse the fasting state	
treat seizures with a short-acting benzodiazepine (e	
not yet approved in the us)	
some individuals recover with a glucose infusion only	
200 mg once daily is appropriate for most individuals	
the following responses to hematin infusion can be expected:	
chronic (cutaneous) manifestations	
grey or smoke colored filters provide only partial protection	
pharmacologic agents may suppress abnormal movements	
tremor in one individual was suppressed with clonazepam	
no specific therapy is currently available for alsp	
other:	
treatment should be coordinated through a hemophilia treatment center	
(individuals in the usa see national hemophilia foundation	
immunizations should be administered preferably subcutaneously	
ddavp®	
(desmopressin acetate)	
immune tolerance therapy	
elsewhere worldwide: see world federation of hæmophilia)	
immunizations should be administered subcutaneously	
inhibitors	C0243077//inhibitors//MSH
clinical	C0205210//Clinical//MTH	C3272565//Clinical Lot//MTH
biochemical	C0205474//Biochemical//MTH
non-expressing p	
cys282tyr homozygotes	
variceal bleeding	
transjugular intrahepatic portosystemic shunts (tips) are widely available	
hypersplenism	C0020532//Hypersplenism//MSH
hypersplenism usually does not result in clinically significant sequelae	
abnormalities of the biliary tree	
cholangitis is best treated with rapid institution of appropriate antibiotics	
biliary stones	C0008350//Cholelithiasis//MTH	C0242216//Biliary calculi//MTH	C0267869//Bile duct calculus//MTH
cholangiocarcinoma and hepatocellular carcinoma	
these should be managed by a multidisciplinary team	
patient education	C0030688//Patient education (procedure)//MTH
urologic referral is indicated	
gynecologic referral is indicated	
hymenectomy may be necessary for tight constriction ring	
however, no data on its use are available	
lymphedema management (manual lymphatic drainage, compression)	
muscle	C0026845//Muscle//MTH
physical therapy and exercise to promote mobility and prevent contractures	
lung	C0024109//Lung//MTH
noninvasive ventilation if needed	
pancreas	C0030274//Pancreas//MTH	C0771711//Pancreas extract//MTH
treatment of pancreatic exocrine insufficiency with pancreatic enzyme supplementation	
treatment of cholestasis with ursodeoxycholic acid	
enteral feeding as needed	
surgical removal of visually significant cataracts	
the primary curative treatment of gastric cancer is surgical resection	
frequent small meals tend to maximize caloric intake	
stiffened peripheral vasculature may be less tolerant to dehydration	
therefore maintaining optimal hydration orally is recommended	
infections are generally handled as for unaffected children	
anesthetics should be used with particular caution	
nitroglycerin is frequently of benefit if angina develops	
statins are recommended for their putative effect on farnesylation inhibition	
injuries	C1510467//trauma qualifier//MTH	C3263723//Traumatic injury//MTH
wound healing is normal	
fracture rate is equivalent to the general pediatric population	
hips	C0019552//Hip structure//MTH
teeth	C0040426//Tooth structure//MTH	C1519551//Odontogenic Tissue//MTH	C2239132//examination of teeth//MTH
, finger) joints	
eye care	C0885957//Eye care (regime/therapy)//MTH
hearing aids can be used, when clinically necessary	
treatment of acute hyperammonemic episodes	
, as part of nitrogen scavenging therapy)	
this approach also stops all protein intake	
infusion 1	
infants and children	
adolescents and adults	
10% arginine hcl	
210 mg/kg/day	
drug	C0013227//Pharmaceutical Preparations//MTH	C1254351//Pharmacologic Substance//MTH
action	C0441472//Clinical action//MTH	C1552007//control act - action//MTH	C3266814//Action//MTH
glucose	C0017725//Glucose//MTH	C0337438//Glucose measurement//MTH
arginine 1	
sodium benzoate 3	
sodium phenylacetate 3	
hemodialysis	C0019004//Hemodialysis//MTH	C1524112//Drug Administration via Hemodialysis//MTH
dialysis may be prolonged if the catabolic state persists	
note: non-essential amino acids (i	
nosebleeds	C0014591//Epistaxis//MTH
oral drug therapy	
topical drug therapy	
, timolol 0	
gastrointestinal bleeding	C0017181//Gastrointestinal Hemorrhage//MSH
pulmonary avms	
hepatic avms	
cerebral avms	
cerebral avms greater than 1	
intestinal polyps	C0021846//Intestinal Polyps//MSH
most investigators recommend maintaining all glucose levels above 3	
somatostatin analogs (e	
glucagon, which increases hepatic gluconeogenesis, helps prevents hypoglycemia	
however, therapeutic success has not been confirmed	
dietary intervention:	
night-time continuous gastric drip containing glucose or glucose polymer	
in such individuals, surgery must be considered	
if structural damage to the lungs (e	
, pseudomonas) or fungi (e	
, aspergillus)	
adequate skin lubrication is needed with frequent bleach baths	
hlh-1994	
hlh-2004	
in general, treatment involves the following:	
after achievement of clinical remission in simplex cases (i	
, a single occurrence in a family)	
cutaneous lesions	
cutaneous leiomyomas should be examined by a dermatologist	
treatment of cutaneous leiomyomas is difficult:	
surgical excision may be performed for a solitary painful lesion	
lesions can be treated by cryoablation and/or lasers	
uterine fibroids should be evaluated by a gynecologist	
hysterectomy should be performed only when necessary	
renal tumors	C0022665//Kidney Neoplasm//MTH
early detection of kidney tumor in hlrcc is important	
chelation therapy with disodium calcium edetate	
short term	C0443303//short-term//CHV
, >3 hours)	
long term	C0443252//Long-term//MTH
chelation therapy should be continued lifelong	
iron therapy	
iron is a competitive inhibitor of intestinal manganese uptake	
dystonia can result in physical deformities and pain	
at present no disease-modifying therapy exists	
pain management is the primary goal of therapy:	
cleft palate is best managed by a local craniofacial team	
management of colon cancer in a person with lynch syndrome	
complications should be managed appropriately (e	
multidisciplinary management at various ages may include:	
endocrinology to optimize bone homeostasis and avoid exacerbating treatments	
nephrology to monitor calcium homeostasis and examine for nephrocalcinosis	
neurology to prophylactically or prospectively treat seizures and manage myopathy	
neurosurgery or craniofacial team to manage pseudocraniosynostosis	
orthopedics to manage primary and secondary skeletal manifestations	
pain management	C0002766//Pain management//MTH
pediatric and adult dentistry to manage tooth loss	
enzyme replacement therapy	C0598391//Enzyme Replacement Therapy//MSH
perinatal/infantile hpp study outcomes	
survival	C0038952//Continuance of life//MTH	C0220921//survival aspects//MTH
bone findings	
juvenile-onset hpp study outcomes	
age at treatment onset was six to 12 years	
perinatal types	
infantile type	
in the absence of ert, supportive management remains	
calcium homeostasis	C3653518//CALCIUM HOMEOSTASIS//ATC
craniosynostosis in those with the infantile phenotype is variable	
childhood (juvenile) and adult hypophosphatasia	
osteoarthritis may respond to nsaids	
pseudofractures and stress fractures are difficult to manage	
early surgical repair may improve feeding	
the principles of treatment are summarized in table 7	
goal	C0018017//objective (goal)//MTH	C1571704//Act Mood - Goal//MTH
means	C1704970//Means//MTH
practical details	
to avoid triggering or aggravating factors for paralytic attacks	
avoid:	
strenuous effortprolonged immobilitycarbohydrate-rich diet	
treatment of paralytic attack:	
shorten/prevent aggravation of the weakness episodenormalize kalemia	
preventive treatment for paralytic attacks	
daily k+ supplementation	
slow-release forms of potassium may be used	
diamox (acetazolamide)	
k+-sparing diuretics	
preventive treatment for late-onset myopathy	
diamox (acetazolamide)?	
medical precautions	
other elements of management	
strenuous effort	
prolonged immobility	
carbohydrate-rich diet	
provide dietary review/counseling	
shorten/prevent aggravation of the weakness episode	
normalize kalemia	
avoid glucose intake	
do not use slow-release forms of potassium	
oral potassium: initially, 1 meq/kg	
3 meq/kg after 30 minutes if no improvement	
iv potassium: 0	
avoid corticosteroids if possible	
kinesitherapy in case of permanent pelvic deficit	
paralytic crisis	
mild to moderate paralytic episodes	
aqueous potassium contained in vials may act more rapidly	
, 4	
3 meq/kg can be administered (20 meq	
, 1	
severe paralytic episodes	
note the following critical points:	
3 meq/kg/h of potassium (i	
some individuals exhibit serious arrhythmias with only mild hypokalemia	
they are associated with a risk for cardiac arrest	
attempting to abort paralytic attacks when they begin	
correction of these refractive errors can improve visual acuity	
the surgery is not always successful	
humidifiers may reduce the frequency of nosebleeds	
oral contraceptives can limit the duration of menstrual periods	
the authors know of several additional successful lung transplantations	
primary hyperparathyroidism	C0221002//Hyperparathyroidism, Primary//MSH
minimally invasive parathyroidectomy requires the use of:	
preoperative imaging (e	
jaw tumors	
uterine tumors	
a diabetic clinic is a good source of advice	
appropriate shoes and socks are recommended	
it is best to prevent callous formation in neuropathic skin	
hyperthermia or hypothermia	
hypothermia responds to warming by a blanket as necessary	
of note, longstanding infections require wide surgical debridement	
bone and joint deformities can be managed by corrective osteotomy	
joint dislocations are best treated conservatively	
the oral self-mutilation (i	
6-0	
see warren & nade [1999]	
charcot joints may require arthrodesis	
opiates are contraindicated as hsn1a is a chronic disorder	
current recommendations:	
commonly required interventions include the following:	
shunting for hydrocephalus	
tonsillectomy and adenoidectomy	C0193959//Tonsillectomy and adenoidectomy//SNOMEDCT_US
positive pressure ventilation (cpap or tracheostomy)	
carpal tunnel release	C0196576//Decompression of median nerve//SNOMEDCT_US
cardiac valve replacement	
inguinal hernia repair	C0021446//Repair of inguinal hernia//MTH
hip replacement	C0392806//Hip Replacement Arthroplasty (procedure)//MTH
developmental, occupational, and physical therapy are often necessary	
for further information about eculizumab, click here	
typically, plasma exchange is undertaken daily initially	
cfb	C0009002//Clofibrate//MTH	C1824728//CFB gene//MTH
cfh autoantibodies	
cfi	C0055288//chemotactic factor inactivator//MTH	C1276849//Inactivator chemotaxis (function)//MTH	C1442484//CFI gene//MTH
, persistent severe thrombocytopenia and hemolytic anemia)	
molecular genetic testing can help to define graft prognosis	
c3, cfb, and cfi	
four individuals with isolated	
importantly, there were no ahus recurrences after transplantation	
beta blockers	C0001645//Adrenergic beta-Antagonists//MTH
l-type calcium channel blockers	
note: direct vasodilators (e	
dose is based on response to therapy	
gout typically responds well to prednisone or colchicine	
prednisone is the preferable alternative	
fludrocortisone treatment (0	
mineralocorticoid replacement	
kidney transplantation cures adtkd-ren	
treatment for hyperpp is symptomatic and not curative	
, 2 g glucose per kg body weight)	
1 mg salbutamol	
calcium gluconate (0	
adults with fh	
risk factors (e	
4 mmol/l])	
risk factors:	
clinically evident cad or other atherosclerotic cardiovascular disease	
8 mmol/l)	
diabetes mellitus or metabolic syndrome	
women age <55 years)	
current smoking	
3 mmol/l] using an isoform insensitive assay)	
class	C0456387//Class//MTH	C0489477//LOINC class types//MTH	C1547013//Kind of quantity - Class//MTH	C1705943//Class (taxonomic)//MTH
ldl-lowering response	
statins	C0360714//Hydroxymethylglutaryl-CoA Reductase Inhibitors//MTH
↑ ldlr activity (1o)	
>35% 1, 2	
cholesterol absorption inhibitors (ezetimibe)	
mipomersen (apob antisense) 4	
blocks apob production in the liver	
mtp inhibitor(lomitapide) 4	
pcsk9 inhibitors(alirocumab, evolocumab)	
↓ ldl-receptor degradation	
50% 6	
bile acid sequestrants(cholestyramine, colesevelam)	
stanol esters	
10% 1, 3	
children with fh	
9 mmol/l)	
consultation or referral to a lipid specialist is recommended	
statins are the preferred initial pharmacologic treatment in children	
4 mmol/l)	
children and adults with homozygous fh (hofh)	
nla guidelines for homozygous fh (full text):	
referral to a lipid specialist is indicated	
early initiation of therapy and monitoring are recommended	
multiple drug therapy is usually needed	
many states do not have an apheresis center	
in adults the initial dose is 0	
5 mg twice a day	
the dose can be increased up to 2	
0 mg three times a day	
antiepileptic drugs if epileptic seizures are present	
the usual neurosurgical approach to spinal stenosis is laminectomy	
the l2-3 level most commonly required decompression	
seizure disorders should be treated in the standard manner	
management of blisters in a standard manner (i	
, not opening them, avoiding trauma)	
topical treatment (e	
, medications, oatmeal baths) to relieve discomfort	
significant skin involvement may benefit from dermatology management	
treatment of infections as for any other cellulitis	
standard treatment for retinal detachment	
physical and occupational therapy to promote mobility and independence	
aids for mobility and limb function	
treatment is symptomatic only:	
management should be tailored to the individual	
paget disease of bone	C0029401//Osteitis Deformans//MTH
actonel®/risedronate	
fosamax®/alendronate	
aredia®/pamidronate	
tnfα antagonists have also been used	
growth hormone (gh) therapy	
treatment by a psychiatrist for neuropsychiatric symptoms is indicated	
dopamine agonist therapy has been tried in some cases	
monitor fluid intake to assure adequate intravascular volume	
appropriate medications for management of seizures and spasticity	
chest physiotherapy to prevent respiratory complications	
sleep studies to assess nocturnal hypoventilation and institute appropriate interventions	
assessment for scoliosis	
dietary	C0012155//Diet//MTH	C2699635//Dietary Route of Administration//MTH
medical	C0199168//Medical service//MTH	C0205476//Medical//MTH	C1547184//Medical school type//MTH	C1561579//Medical referral type//MTH
management focuses on rehabilitation to optimize mobility and communication	
treatment of seizures follows standard management principles	
treatment of iron overload	
it is simple, safe, and effective	
the hematocrit should be monitored prior to phlebotomy	
usually four to six phlebotomies annually are sufficient	
treatment of secondary complications	
transdermal preparations (i	
arthropathy is not modified by treatment	
cirrhosis is thought to be irreversible despite iron removal	
diabetes mellitus may require insulin administration	
cardiac issues	
even with additional therapies (e	
qtc interval >550 msec	
syncope before age five years	
left cardiac sympathetic denervation has been effective for some individuals	
iron deficiency anemia	C0162316//Iron deficiency anemia//MTH
hypotonia and therapeutic interventions	
periodic neuropsychologic and developmental testing at appropriate ages	
other cns malformations	
posterior fossa cysts and fluid collections rarely require intervention	
encephalocele may require primary surgical closure	
corrective lenses for refractive errors	
consultation with a nephrologist is indicated	
hepatic fibrosis	C0239946//Fibrosis, Liver//MSH
consultation with a gastroenterologist is indicated	
some individuals have needed orthotopic liver transplantation	
surgical treatment for polydactyly	
appropriate medical management by an orthopedic specialist for scoliosis	
orofacial clefting is treated by standard surgical interventions	
no specific guidelines are currently available	
jps	C0345893//Juvenile polyposis syndrome//MTH
jps/hht	C1832942//JUVENILE POLYPOSIS/HEREDITARY HEMORRHAGIC TELANGIECTASIA SYNDROME (disorder)//MTH
treat manifestations of hht as needed	
see hereditary hemorrhagic telangiectasia	
monitoring for nocturnal lagophthalmos by parents or caregivers is recommended	
if present, evaluation by an ophthalmologist is indicated	
skeletal features	
early referral to physical therapy to help increase joint mobility	
orchiopexy in males with undescended testes	
anal anomalies	
referral to an urologist or nephrologist as indicated	
facial features	C0871976//facial features//CHV
hearing aids as needed for hearing loss	
no specific management guidelines have been developed	
management is mostly supportive	
lacrimal duct obstruction	C0022906//Lacrimal Duct Obstruction//MTH
tear duct massage	
consider lacrimal duct stent placement	
cleft palate, bifid uvula, or velopharyngeal insufficiency	
management by a cleft/craniofacial team	
cpap or bipap	
ent evaluation for tonsillectomy/adenoidectomy	
pulmonary consultation	
feeding difficulties or signs of aspiration	
use of a special nipple or bottle with cleft palate	
short-term nasogastric feeding tube	
consideration of gastrostomy tube	
gastroesophageal reflux disease	C0017168//Gastroesophageal reflux disease//MTH
standard positioning & pharmacologic treatment	
musculoskeletal findings (i	
, contractures, scoliosis)	
ankle-foot orthoses or other assistive devices	
physical therapy and/or occupational therapy evaluation	
consultation w/an orthopedist	
seizure disorder	C0014544//Epilepsy//MTH
evaluation of blood sugar & electrolytes	
standard treatment for seizures	
consider eeg and referral to a neurologist	
unexplained hypoglycemia or suspected hyperinsulinism	
consideration of diazoxide therapy	
consider referral to an endocrinologist	
consider referral to a neurodevelopmental specialist and/or neuropsychiatric testing	
benign familial neonatal epilepsy (bfne)	
all but three had family histories of neonatal seizures	
pathogenic variants in kcnq3 were present in two	
earlier initiation of cbz was associated with shorter hospitalization	
no side effects of cbz were reported	
8 years)	
benign familial infantile epilepsy (bfie)	
no established treatment for kindler syndrome exists	
standard blister care in childhood	
antibiotics may be used to treat an infected blister	
use of moisturizers for dry, pruritic skin	
mucosal involvement	
mouth and periodontium	
gastrointestinal tract	C0017189//Gastrointestinal tract structure//MTH
esophageal dilatation may be indicated for those with dysphagia	
anal stenosis and bleeding requires regular laxatives	
severe colitis may require surgical bowel resection in some cases	
urethra	C0041967//Urethra//MTH	C1547951//Urethra specimen code//MTH	C1550675//Urethra specimen//MTH
meatal stenosis may require dilatation	
strictures may require stenting and/ or surgical intervention	
phimosis	C0031538//Phimosis//MTH	C0034919//Redundant prepuce and phimosis//SNOMEDCT_US	C0345326//Congenital phimosis//MTH	C0403766//Acquired phimosis//MTH
no well-controlled treatment trials have been reported	
specialized neurologic care for individuals with epilepsy	
males with igd age ≥18 years	
hormone replacement therapy for males not desiring fertility	
doses do vary with newer testosterone preparations	
if testosterone levels fall, therapy should be reinitiated	
human chorionic gonadotropin (hcg)	C1141639//Human Chorionic Gonadotropin//MTH
male infants/adolescents with suspicion of igd	
if igd is clinically suspected (e	
fsh is added at doses ranging from 37	
5 to 75 iu as either hmg or recombinant formulation	
pulsatile gnrh stimulation vs	
females with igd	
hormone replacement therapy for females not desiring fertility	
many formulations of estrogens are available	
a suggested oral regimen is using premarin 0	
25 mg daily	
in vitro fertilization	C0015915//Fertilization in Vitro//MTH	C0733942//Encounter due to In vitro fertilization//MTH
the following treatment recommendations are appropriate:	
educational intervention and speech therapy beginning in infancy	
cataract and ptosis surgery if indicated	
hearing aids or cochlear implant if needed	
cardiac function assessment and treatment if needed	
orchidopexy in males with undescended testes	
treatment of vesicoureteral reflux if indicated	
other facial	
cleft palate repair if present	
placement of eyelid slings for severe ptosis	
cochlear implants and hearing aids for neurosensory hearing loss	
hormone replacement for endocrinopathies	
dilation of the upper esophageal sphincter to alleviate cricopharyngeal achalasia	
replacement of pancreatic enzymes in pearson syndrome	
treatment of depression	
ventilatory support for respiratory abnormalities in leigh syndrome	
surgical treatment should be performed as needed	
developmental progress should be monitored and stimulated	
adducted thumbs	C3554617//Adducted thumb//HPO
surgical intervention is not generally indicated	
a splint may help reduce the degree of adduction	
neurologic features should be monitored	
follow up and treatment is nonspecific	
autonomic dysfunction	C1145628//Autonomic nervous system disorders//MTH
neurogenic bladder:	
urinary urgency may require spasmolytics (e	
, solifenacine succinate)	
, docusate) or a laxative is needed	
sexual dysfunction can be alleviated with sildenafil	
anhidrosis is managed by avoiding overheating	
cognitive dysfunction can affect social interactions and financial management	
valproic acid is the traditional antiepileptic treatment for ld	
wolman disease	C0043208//Wolman Disease//MTH	C1416865//LIPA gene//MTH
malabsorption and malnutrition	
hepatomegaly and liver disease	
adrenal cortical insufficiency	C0405580//Adrenal cortical hypofunction//MTH
consider discussion of comfort care options	
cesd	C0043208//Wolman Disease//MTH	C1416865//LIPA gene//MTH
lipophilic vitamin supplementation may also be beneficial	
the following as needed:	
recurrence is possible even with more definitive treatment	
surgery for ptosis if clinically indicated (e	
, obscured vision, cosmetic appearance)	
individualized education plans for learning disorders and school performance issues	
biotin-thiamine-responsive basal ganglia disease	C1843807//Basal ganglia disease, biotin-responsive//MSH
biotinidase deficiency	C0220754//Biotinidase Deficiency//MTH
(btd)	
coenzyme q10 biosynthesis deficiency	
(pdss2)	
early intervention with special education maximizes cognitive development	
referral to services for the visually impaired is recommended	
treatment of hearing loss may include the following:	
extrapyramidal manifestations	
dystonia and dyskinesias may cause significant disability	
pharmacologic treatment may result in significant functional improvement	
cognitive developmental delay/encephalopathy	
augmentative communication may be used to address speech deficits	
referral to a cardiologist for standard supportive treatment of cardiomyopathy	
clinical genetics consultation	
avoidance of prolonged immobility is recommended	
there is no curative therapy for lp	
treatments of unproven efficacy	
click here (pdf) for further details	
specific treatment for lms does not currently exist	
lateral spinal meningoceles	
symptomatic treatment of neurologic sequelae (e	
physiotherapy to reduce risk for joint subluxation and dislocation	
routine management of the following:	
congenital cardiac defects	
hyperuricemia	C0740394//Hyperuricemia//MSH
allopurinol therapy results in the accumulation of hypoxanthine and xanthine	
xanthine may also form stones	
hypoxanthine is soluble	
neurologic dysfunction	C0751377//Neurologic Dysfunction//MSH
two important considerations when managing cardiovascular features of lds:	
vascular disease is not limited to the aortic root	
0 cm	
0 cm and the excellent response to prophylactic surgery	
clubfeet require surgical correction by an orthopedic surgeon	
surgical intervention for protusio acetabulae is rarely indicated	
treatment focuses on pain control	
orthotics are only indicated for severe pes planus	
some individuals prefer use of arch supports	
others find them irritating	
surgical intervention is rarely indicated or successful	
cataract surgeons and glaucoma specialists may also be needed	
others require surgery	
most seizure disorders can be controlled with anticonvulsant therapy	
early childhood and preschool intervention programs, e	
kidney	C0022646//Kidney//MTH	C0227665//Both kidneys//MTH
, with surgical procedures	
most undescended testes descend with time into the scrotum	
some require hormone therapy and/or surgical correction	
treatment of acute hyperammonemic crises	
pharmacologic management	C0150270//Medication Management//MTH
therapy with ondansetron can be started to decrease vomiting	
dietary protein restriction and citrulline supplementation	
current treatment consists of dietary protein restriction (0	
8-1	
5 g/kg/day in children and 0	
lysine supplementation	
carnitine supplemetation	
additional therapies	
treatment of late complications	
however, relapses may require serial lavage	
medical nutrition therapy	C1257928//Medical Nutrition Therapy//MTH
recurrent or persistent eruptive xanthomas indicate inadequate therapy	
treatment is largely symptomatic	
oxygen supplementation if necessary	
education on complete bladder emptying when voiding	
medical treatment of pulmonary hypertension (e	
, by sildenafil)	
surgical treatment of congenital diaphragmatic hernia or severe hiatal hernia	
physical therapy for muscle strength and joint stability	
psychosocial support	C2242840//psychosocial support (history)//MTH	C2958078//Psychosocial care (regime/therapy)//MTH	C3665378//psychosocial assessment/care//MTH
painful bilateral madelung deformity (uncommon)	
audiologist	C0175838//Audiologist//MTH
dietitian	C3536818//Dietitian//MTH
clinical geneticist and genetic counselor	
nurse coordinator	
ophthalmologist	C1704292//Ophthalmologist (occupation)//MTH
oral and maxillofacial surgeon	C0260272//Oral and Maxillofacial Surgeons//MSH
orthodontist	C0260083//Orthodontist//MTH
orthopedist	C0334891//Orthopedic Surgeons//MTH
otolaryngologist	C0260087//Otolaryngologist//MTH
pediatric dentist	C0586985//Pedodontist//MTH
pediatrician	C0237433//Pediatrician (occupation)//MTH
plastic and reconstructive surgeon	
psychosocial professionals (psychologist, social worker)	
speech pathologist	C0402015//Speech/language therapist//MTH
referral to a craniofacial center or otolaryngologist is recommended	
face	C0015450//Face//MTH	C1423759//ELOVL6 gene//MTH	C2828055//FANCE wt Allele//MTH	C3160739//FANCONI ANEMIA, COMPLEMENTATION GROUP E//MTH	C4284034//Face (spatial concept)//MTH
jaw and teeth	
good oral hygiene is especially important for children with cfm	
children should have consistent primary preventative dental care	
early referral to an otolaryngologist is recommended	
this surgery typically occurs after age five years	
speech	C0037817//Speech//MTH	C0846595//Speech assessment//MTH	C2137063//ENT surgical result - speech//MTH
ears	C0013443//Ear structure//MTH	C0521421//Entire ear//MTH	C1414437//EPRS gene//MTH
options for management of microtia include the following:	
no action	
prosthetic management, either adhesive or implant-retained	
family and social support	
crmo is treated as follows:	
thus, their efficacy in this disorder is unknown	
physical therapy to avoid disuse atrophy of muscles or contractures	
colon polyps and colon cancer	
colonoscopy is effective surveillance for colon cancer	
duodenal polyps	C0347266//Polyp of duodenum//SNOMEDCT_US
management of polyps is similar to individuals with fap	
protusio acetabulae can be associated with pain or functional limitations	
surgical intervention is rarely indicated	
orthotics are indicated only in severe cases	
surgical intervention is rarely indicated or fully successful	
pneumothorax can be a recurrent problem	
school-age children benefit from an individualized educational program	
no information is available on response to specific aeds	
fibrous dysplasia	C0259779//Fibrous Dysplasia//MTH
the primary elements of management include the following	
see fibrous dysplasia management (pdf):	
see precocious puberty management in girls (pdf)	
see gonadal involvement management in boys (pdf)	
, letrozole) [boyce et al 2012]	
thyroid disease	C0040128//Thyroid Diseases//MTH	C2186538//reported prior thyroid disease (history)//MTH
see hyperthyroidism management (pdf)	
methimazole is effective for management of hyperthyroidism	
the risk may potentially be enhanced by radiation exposure	
growth hormone (gh) excess	
see gh excess: management (pdf)	
medical therapy is the preferred first-line treatment	
fgf23-mediated phosphate wasting	
hypercortisolism	C0001622//Adrenal Gland Hyperfunction//MTH	C0010481//Cushing Syndrome//MTH	C4025651//Increased circulating cortisol level//MTH
see hypercortisolism management (pdf)	
definitive treatment includes surgical removal of the diseased adrenal glands	
care by a nephrologist is recommended	
gout prevention with allopurinol or probenecid should be considered	
kidney disease	C0022658//Kidney Diseases//MTH
kidney transplantation cures adtkd-umod	
treatment of psychiatric problems according to the clinical presentation	
antiepileptic drugs (aeds) for treatment of seizures	
early-onset	C1833334//Early-onset//OMIM
nutrition/weight	
weight needs to increase annually by small increments	
gastroesophageal reflux is treated as needed	
respiratory function testing	
assistance with coughing	
noninvasive ventilation support is indicated in the setting of:	
daytime hypercapnea and/or nocturnal hypoventilation	
toddlers often fight the masks	
non-ambulant children require standing frames for postural support	
late-onset	
antiepileptic drugs should be used to treat seizures	
additional management in healthy adults who have the 15q13	
, schizophrenia)	
routine treatment of ophthalmologic, cardiac, neurologic findings	
speech, occupational, and physical therapies	
because manifestations of 16p12	
early diagnosis and treatment facilitate the best outcome	
developmental and cognitive delays	
initiate developmental therapies promptly when indicated	
individuals with 16p12	
psychiatric and/or behavior problems	
standard treatment should be provided for hearing loss	
other malformations	
mody5	C0431693//Renal cysts and diabetes syndrome//MTH	C1420636//HNF1B gene//MTH	C2348633//HNF1B wt Allele//MTH
neurodevelopmental/neuropsychiatric disorders	
routine medical care by a pediatrician or other primary physician	
speech therapy directed at improving verbal and nonverbal communication skills	
the seizures usually are easy to control with medication	
treatment for cryptorchidism if indicated	
routine treatment of ophthalmologic, cardiac, and neurologic findings	
speech, occupational, and physical therapies, as appropriate	
early speech and language therapy to address speech delays	
individualized education program (iep) for school-age children	
applied behavioral analysis or other treatment for manifestations of asd	
ataxia may require assistive devices or eventually wheelchair	
consultation with a speech pathologist may be helpful	
cognitive impairment	C0338656//Impaired cognition//MTH
developmental stimulation including speech therapy is appropriate	
treatment is nonspecific	
predisposition to infections	C0239998//Recurrent infections//MTH
all vaccines should be given	
gastrointestinal dysfunction	C0679407//Gastrointestinal dysfunction//OMIM
for (progressive) spasticity	
for excessive drooling	
patients experienced great improvement (e	
for failure to thrive	
no therapy is available for peo or retinopathy	
physical therapy should be implemented in individuals after strokes	
seizures respond to traditional anticonvulsant therapy	
standard analgesics can be used for migraine headaches	
cardiac manifestations can benefit from standard pharmacologic therapy	
phpt	
subtotal parathyroidectomy (i	
removal of ≤3	
pituitary tumors	C0032019//Pituitary Neoplasms//MTH
prl-secreting tumors (prolactinomas)	
growth hormone-secreting tumors	
acth-secreting tumors	
non-secreting pituitary adenomas	
gastrinoma	C0017150//Gastrinoma//MSH	C0043515//Zollinger-Ellison syndrome//MTH
pancreatic tumors	C0030297//Pancreatic Neoplasm//MTH
the optimal therapy of gastrinoma is controversial	
occult metastatic disease (i	
carcinoid tumors	C0007095//Carcinoid Tumor//MTH
adrenocortical tumors	
medullary thyroid carcinoma (mtc)	
menkes disease	C0022716//Menkes Kinky Hair Syndrome//MTH
surgery for bladder diverticula that occur in classic menkes disease	
developmental intervention	
atp7a-related dmn	
physical therapy (strength and stretching exercises)	
occupational therapy	C1318464//Occupational therapy regime//MTH	C1547993//Diagnostic Service Section ID - Occupational Therapy//MTH
ankle foot orthotics	
the seizure disorder can be treated with conventional anticonvulsant therapy	
clonazepam can also reduce myoclonus	
physical therapy is helpful for any impaired motor abilities	
standard pharmacologic therapy is used to treat cardiac symptoms	
mandibulofacial dysostosis	C0242387//Mandibulofacial Dysostosis//MTH
see esophageal atresia/tracheoesophageal fistula overview	
thumb anomalies	C1273564//Congenital malformation of thumb//MTH
other thumb anomalies are not generally functionally significant	
short stature is managed expectantly	
treatment of scoliosis by spinal fusion is appropriate	
orthoses are indicated for treatment of foot drop	
discontinue use of potent inhalation agents and succinylcholine	
increase minute ventilation to lower end-tidal co2	
get help	
prepare and administer dantrolene: 2	
5 mg/kg initial dose	
tachycardia, hypercarbia, and muscle rigidity respond rapidly	
multiple doses of dantrolene may be needed	
the suggested upper limit is 10 mg/kg	
however, more may be given as needed	
continue dantrolene at 1	
dantrolene may aggravate previously existing muscle weakness	
begin cooling measures	
stop cooling measures at core body temperature of 38	
5° c	
treat cardiac arrhythmias as needed	
do not use calcium channel blockers	
check values every six to 12 hours	
the earliest sign of rhabdomyolysis is myoglobinuria/myoglobinemia	
serum ck levels may not rise for several hours	
ensure urine output of 2	
evaluate need for invasive monitoring and continued mechanical ventilation	
myoglobinuria	C0027080//Myoglobinuria//MTH
physical habilitation	
standard care for other medical issues (e	
therapy is supportive and involves the following:	
special education programs tailored to the needs of the individual	
speech and language therapy	C0037831//Speech Therapy//MTH
behavioral therapy as needed	
occupational therapy as needed	
community services that provide support for families	
ritalin® may be helpful to treat marked hyperkinesia	
objective efficiency of gh therapy has not been evaluated	
use of a prosthesis in severe microphthalmia and anophthalmia	
, fitting stockings, massage) is important	
adaptation of the school environment (e	
no definitive treatments exist for the limb-girdle muscular dystrophies	
standard treatment is indicated for the following:	
polydactyly and syndactyly	
anal anomalies and hirschsprung disease (surgical treatment)	
joint	C0022417//Joints//MTH	C0392905//Articular system//MTH	C1269611//Entire joint//MTH	C1706309//Joint Device Component//MTH
intellectual impairment in ml ii is rarely severe	
severe gingival thickening can compromise routine dental cleaning	
otic	C0521422//Otic//MTH	C1272926//Otic dosage form//MTH	C1522191//Auricular Route of Drug Administration//MTH
the recommended dose is 1 mg/kg monthly	
bone density needs to be monitored closely	
the long-term effect(s) are unknown	
sillence, personal communication]	
not all affected individuals benefit from bisphosphonate treatment	
the prevalence decreases with age	
psychosocial support of patients and families is recommended	
management of pain in the hips is required	
surgical correction of strabismus	
speech therapy as needed	
pulmonary function and vision may also need attention	
stabilization of critically ill individuals	
volume replacement with isotonic solutions	
adequate kcals must be delivered	
once symptoms appear, treatment is primarily supportive	
management of gi dysfunction can include the following:	
trial of dromperidone for nausea and vomiting	
celiac plexus block with bupivicaine	
physical therapy and occupational therapy to help preserve mobility	
activity as tolerated should be encouraged	
osteopenia and osteolysis	
at present no specific therapy can alleviate the progressive osteopenia	
nonsteroidal anti-inflammatory drugs may not provide sufficient relief	
provide medical or surgical interventions as appropriate	
monosomy 7 in children with de	
novo aml (i	
eye anomalies	
notched or bifid nose	
rhinoplasty may be performed for cosmetic purposes	
anal stenosis is generally managed by serial dilatations	
the cardiomyopathy may respond to ace inhibitors or other medication	
cardiac consultation is recommended	
kyphoscoliosis may be treated with surgical stabilization of the spine	
there is no treatment for spinal rigidity	
these agents are not widely used in children	
renal allografts	
001)	
005)	
allograft survival appears to be age-dependent in ddd	
neurosurgical complications (hydrocephalus and cerebellar tonsillar ectopia)	
epilepsy may require long-term antiepileptic treatment	
developmental delays	
joint replacement and atlanto-occipital stabilization may be necessary	
repeated surgery may be required	
cardiac valve replacement should be considered early	
hearing aids should also be considered	
ent (otolaryngologic)	
gastrointestinal system	C0012240//Gastrointestinal system//MTH	C0017189//Gastrointestinal tract structure//MTH	C1333803//Gastrointestinal System Finding//MTH
hydrocephaly	C0020255//Hydrocephalus//MTH	C3887608//HYDROCEPHALUS, NONSYNDROMIC, AUTOSOMAL RECESSIVE 1//MTH
early surgical intervention may prevent severe complications	
physical therapist to optimize mobility	
occupational therapist to optimize autonomy	
psychological support to optimize coping skills and quality of life	
educational professions to optimize learning in a medically fragile individual	
home care for affected individuals with multiple medical equipment needs	
hospice for end-of-life care	
enzyme replacement therapy (ert)	
the recommendation dose is 2 mg/kg/week intravenous	
upper extremities	C1140618//Upper Extremity//MTH
knee and ankle valgus	
however, no absolute indications for intervention exist	
hip dysplasia	C0019555//Hip Dislocation, Congenital//MTH	C1328407//Hip Dysplasia//MTH
affected individuals undergoing surgical fusion typically do well	
lumbar spine malalignment	
when kyphosis exceeds 45 degrees, progression is likely	
progressive thoracolumbar kyphosis greater than 70 degrees	
uncontrolled back pain	
neurologic changes related to spinal stenosis	
thus tachycardia treatment with beta blockers should be avoided	
restrictive lung disease is managed by supportive treatment	
learning environment	C1510556//Learning Environment//PSY
cataract surgery may benefit those with cataracts	
orthodontic management to correct malocclusion may be necessary	
prevention of hypoglycemia requires frequent feeds and avoidance of fasting	
hepatocellular carcinoma	C2239176//Liver carcinoma//MTH
treatment of muscular manifestations is symptomatic	
cataracts are removed surgically during the first decade of life	
hypergonadotropic hypogonadism (i	
home therapy	C0868969//home therapy//CHV
acute decompensation	
indication for hospitalization	
number	C0237753//Numbers//MTH	C0449788//Count of entities//MTH	C1554106//MDF AttributeType - Number//MTH
vomiting and viral gastroenteritis	
viral bronchiolitis	C0006274//Bronchiolitis, Viral//MSH
sinusitis	C0037199//Sinusitis//MTH
neonatal encephalopathy	C0235820//Neonatal encephalopathy//SNOMEDCT_US
urinary tract infection	C0042029//Urinary tract infection//MTH	C0262655//Recurrent urinary tract infection//MTH
cellulitis	C0007642//Cellulitis//MTH	C0424624//Cellulite//MTH	C2025995//cellulitis on exam (physical finding)//MTH
influenza	C0021400//Influenza//MTH	C0021403//Influenza virus vaccine//MTH
viral meningitis	C0025297//Viral meningitis//MTH
bacterial pharyngitis	C1141882//Pharyngitis bacterial//MDR
esophageal candidiasis	C0239295//Candidiasis of the esophagus//SNOMEDCT_US
appendicitis	C0003615//Appendicitis//MTH
the primary goals of in-hospital therapy	
25 mosm/l per hour	
minimize exposure to hypotonic fluid sources	
the most commonly encountered are hypokalemia and hypophosphatemia	
methods of achieving these goals	
identify and treat precipitating conditions (e	
, infection, inflammation, and fever)	
administer antiemetics (e	
, odansetron 0	
15 mg/kg/dose) to control nausea and vomiting	
provide at least 1	
10 units/kg/hour and titrated to maintain euglycemia	
5 g/kg/day	
provide specific amino acid supplements during metabolic crisis:	
isoleucine and valine	
20-120 mg/kg/day each	
glutamine and alanine	
tyrosine	C0041485//Tyrosine//MTH	C0337446//Tyrosine measurement//MTH
strauss & morton, unpublished observation]	
nutrient	C0678695//Nutrients//MTH	C2347375//Nutrient (property)//MTH
age in months (# of persons)	
0-2 (31)	
3-5 (18)	
6-8 (21)	
9-12 (18)	
13-18 (21)	
19-24 (18)	
25-36 (32)	
leucine (mg)	
72(64-84)	
58(47-68)	
44(37-51)	
35(30-41)	
33(26-39)	
27(22-28)	
21(20-25)	
energy (kcal)	
111(103-119)	
99(94-107)	
89(82-99)	
78(71-87)	
67(55-77)	
57(49-71)	
38(39-51)	
total protein (g)	
1-2	C1519043//Phase I/II Trial//MTH	C3843716//1-2//MTH
5(1	
isoleucine supplement (mg)	
4(0-7)	
3(0-3	
7(0-3	
6(0-3	
8(2	
1-5	
7(1	
5(3	
valine supplement (mg)	
5(9	
8-14	
4(9	
0-13	
0(9	
5-12	
1(6	
8(5	
4-10	
2(2	
8(4	
9-8	
alanine intake (mg)	
233(200-262)	
209(197-234)	
206(193-225)	
189(168-218)	
178(159-199)	
159(140-192)	
117(114-149)	
glutamine intake (mg)	
416(361-471)	
363(337-405)	
358(332-400)	
320(288-371)	
294(252-337)	
256(221-318)	
184(181-235)	
iron (mg)	
1(2	
6-2	
8(1	
zinc (mg)	
6(3	
1-4	
4-4	
9-4	
6(2	
6-3	
selenium (µg)	
0(5	
7-6	
7(4	
8-6	
7(5	
3-6	
3(4	
4-6	
0(4	
0-4	
378(307-401)	
330(307-378)	
330(307-354)	
307(260-354)	
307(283-330)	
283(236-330)	
212(212-260)	
leucine / energy ratio (mg/kcal)	
65(0	
57-0	
72)	
58(0	
48-0	
66)	
56)	
46(0	
37-0	
53)	
48(0	
38-0	
54(0	
44-0	
55)	
control of brain edema	
measure head circumference and fontanel size in neonates	
papilledema	C0030353//Papilledema//MTH
disorientation, combativeness	
depressed level of consciousness	C0549249//Depressed Level of Consciousness//MTH
refractory vomiting	
extremity hyperreflexia	
bradycardic hypertension	
hyperactive gag	
pupillary asymmetry	C0003079//Anisocoria//MSH
ophthalmoplegia	C0029089//Ophthalmoplegia//MTH
decorticate posturing	C0231475//Decorticate posture//SNOMEDCT_US
methods to minimize the possibility of brain swelling:	
elevate the individual's head	
note: give furosemide (0	
methods to manage brain swelling:	
furosemide: 0	
0 mg/kg, followed by	
mannitol: 0	
0 g/kg over 60 minutes, followed by	
hypertonic (3%-5%) saline: 2	
5 meq/kg over 60 minutes	
neuroimaging	C0679575//Neuroimaging//MSH
hemodialysis/hemofiltration	
other potential complications in hospitalized persons with msud:	
monitor for and promptly treat hospital-acquired infections	
superficial and invasive candida infections are common	
the management of enlarged parietal foramina is generally conservative	
associated headaches or seizures should be treated symptomatically	
appropriate rehabilitation, e	
enrollment in educational programs appropriate for the hearing impaired	
for mild keratoderma, use of lotions and emollients	
for severe keratoderma, dermatologic evaluation	
treatment by a psychiatrist for those with significant neuropsychiatric symptoms	
tracheostomy as indicated for difficulty managing secretions	
prevention strategies under investigation	
other disciplines are involved as needed	
this procedure is usually transcranial (i	
severe initial clinical presentation requiring a staged repair	
postoperative increased icp	
recurrent deformity requiring a second transcranial repair:	
seven (24	
1%) of 29 individuals with the p	
3%) of 47 without the pathogenic variant	
048) [thomas et al 2005]	
15 were expected to undergo extracranial contouring	
note that none had increased icp	
hearing loss is often sensorineural	
strabismus surgery/correction is indicated to prevent amblyopia	
evaluation for hscr and ultrashort hscr	
referral to a urologist or nephrologist as indicated	
bleeding tendency	C0005779//Blood Coagulation Disorders//MTH	C1458140//Bleeding tendency//MTH
suturing for treatment of accidental or surgical wounds	
mouthwash with tranexamic acid may control gingival bleeding	
eltrombopag	C1831905//eltrombopag//MTH
antifibrinolytic agents	C0003304//Antifibrinolytic Agents//MTH
ten of them benefited from cochlear implants	
glomerular nephropathy	
dialysis or kidney transplantation is required in individuals with esrd	
cataract surgery remedies clouding of the lens	
elevation of liver enzymes does not require any specific treatment	
treatment is largely symptomatic and may include the following	
elective tracheal surgery/intubation should be avoided	
symptomatic treatment of restrictive lung disease	
oxygen supplementation as necessary	
noninvasive 3d imaging may be preferred	
neuropsychiatric	
global developmental disability/intellectual disability educational issues	
persistent middle ear effusions	
myringotomy tubes as needed	
ophthalmology	C0029087//Ophthalmology specialty//MTH
routine treatment of strabismus and refractive errors	
all experienced substantial improvement of both myoclonus (61	
5%) and dystonia (48	
2%)	
no adverse effects on cognition or affect were noted	
the results of case studies are summarized below:	
no specific therapy currently exists for this disorder	
special education evaluation is indicated for children with dm1	
statins)	
pain management can be an important part of dm1 treatment	
treatment guidelines for dm2 have been published	
no one medication has been consistently effective	
treatment as in the general population for:	
glaucoma	C0017601//Glaucoma//MTH	C0997768//Glaucoma (eukaryote)//MTH	C1962986//Glaucoma Adverse Event//MTH
supportive management includes treatment of the following:	
treatments for nbia are palliative	
botulinum toxin for those with focal dystonia	
l-dopa treatment, which is beneficial in rare cases	
some will develop prominent dyskinesias early in the treatment	
spectacles as needed to correct refractive errors	
orchiopexy as needed	
trihexyphenydil improves dystonia and sialorrhea	
general management	
thiazide diuretics (i	
emergency treatment for dehydration	
5% dextrose in water is the preferred solution	
if administration of iv fluids is required, 2	
special situations	
hydronephrosis, hydroureter, and megacystis	
aggressive treatment of lower respiratory tract infections	
standard treatment of gastroesophageal reflux, if present	
physical therapy for maintenance/improvement of function and joint mobility	
speech therapy if dysarthria and/or hypernasal speech is present	
currently no cure for nephronophthisis exists	
treatment of anemia, hypertension, and proteinuria if present	
dialysis or renal transplantation when patients reach esrd	
botulinum toxin is helpful for painful focal dystonia	
further studies are in progress	
vestibular schwannoma	C0027859//Acoustic Neuroma//MTH
therapy remains primarily surgical	
small vestibular tumors (<1	
lip-reading skills may be enhanced by instruction	
ocular involvement	
infections	C0851162//Infections of musculoskeletal system//MTH	C2707258//Infections:-:Point in time:^Patient:-//MTH	C3714514//Infection//MTH
the spectrum of recurrent infections in nbs is not opportunistic	
puberty and fertility	
females are infertile	
similarly, no male paternity has been reported	
no effective treatment for severe glycine encephalopathy exists	
flusser et al 2005	
van hove et al, unpublished]	
it increases alertness	
nmda receptor site antagonists	
use of each has resulted in improved seizure control	
this may be different in mildly affected children	
blood concentration can be monitored	
seizure control is important for symptomatic benefit	
various antiepileptic drugs have been used with variable success	
most affected individuals need physical therapy	
scoliosis is managed with standard techniques	
chorea	C0008489//Chorea//MTH
children: 0	
adults: 37	
5 mg/day starting dose divided in 2-3 doses	
of note:	
other neurologic manifestations	
pulmonary dysfunction	C1709770//Pulmonary Dysfunction//NCI
treat asthma and interstitial lung disease as needed	
thyroid hormone replacement therapy is recommended	
there is substantial early mortality associated with hypertrophic cardiomyopathy	
significant short stature compared with normal peers	
documented response to gh treatment in studies	
no standard dose has been established	
the increase in height sd varies from 0	
6 to 1	
ophthalmologic evaluation is warranted	
at 23 months of life	
5 months) [walsh et al 2010]	
severe neurodegenerative form (npd-a)	
progressive neurologic disease	
regular consultation with a dietician should be provided	
sleep disorder	C0037317//Sleep disturbances//MTH	C0851578//Sleep Disorders//MTH
npd-b	
most affected individuals have thrombocytopenia	
individuals with symptomatic pulmonary disease may require supplemental oxygen	
no curative therapy for npc exists	
child syndrome	C0265267//Congenital Hemidysplasia with Ichthyosiform Erythroderma and Limb Defects//MSH
oral aromatic retinoids (etretinate) to ameliorate cutaneous symptoms	
topical statins	
dermatologic surgery	C1689943//Dermatologic surgery specialty//MTH	C3266910//Dermatologic Surgical Procedures//MTH
orthopedic abnormalities	
other medical care as appropriate based on clinical findings	
ck syndrome	C3151781//CK SYNDROME//OMIM
antiepileptic drugs (aed) to control seizures	
ophthalmologic management of ocular abnormalities	
ophthalmologic care	
surgery may improve peripheral binocularity or appearance	
nystagmus surgery remains highly controversial	
additional classroom aids may include:	
high contrast reading materials (black on white)	
large font texts or xerographically enlarged worksheets	
computers and tablets with zoom-magnification text software	
skin cancer is treated as for the general population	
a hat with a brim (e	
removal of accessory teeth	
orthodontia for malocclusion	
surgery to repair syndactyly, if present	
routine management of seizures	
physical medicine treatment	
avoid sudden acceleration/deceleration movements	
and avoid throwing a child in the air	
older children should not ride on amusement park rides	
physical activity serves a number of purposes	
analgesics can be used to control pain from fractures	
casts should be small and lightweight	
these studies are still ongoing	
a study comparing pamidronate to zoledronic acid was completed	
to date, the results have not been published	
basilar impression	C0032209//Platybasia//MSH
criteria for surgical intervention are not well defined	
plastic polymers are sometimes used to coat teeth	
outcome data are limited	
management of lethal oi	
other therapies	C0418967//Other Therapy//NCI
, pulse oximeter) and ventilation (i	
ongoing studies have not confirmed this report	
hirschsprung disease	C0019569//Hirschsprung Disease//MTH	C3888239//HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1//MTH
tumors of neural crest origin	
no treatment for opa1 is of proven efficacy	
for treatment of ataxia, see ataxia overview	
hand and foot malformations may also require surgery	
surgical correction of limb bowing has not been reported	
apnea prevention	
treatment as needed by an ophthalmologist	
surgical intervention as needed for hypospadias	
surgical treatment of medically significant laryngotracheoesophageal (lte) abnormalities	
surgical management for cleft lip/palate and other craniofacial anomalies	
neuropsychological support	
surgical intervention for imperforate anus	
surgical repair as needed for heart defects	
ptosis	C0005745//Blepharoptosis//MTH	C0033377//Ptosis//MTH
however, the procedure requires general anesthesia	
food should be cut into small pieces	
care of hyperammonemic coma	
rapid lowering of the plasma ammonia	
ammonia scavenger therapy	
citrulline is supplemented at 170 mg/kg/day or 3	
8g/m2/day (enterally)	
table 2	
patient weight	
components of infusion solution	
loading 1 and maintenance dose 2, 3	
sodium phenylacetate & sodium benzoate 4	
arginine hcl injection, 10%	
arginine hcl 5	
<25 kg	
undiluted: 2	
0 ml at 100 mg/ml	
200 mg/kg	
≥25 kg	
40 ml at 100 mg/ml	
4,000 mg/m2	
protein intake	C0489617//protein intake//CHV
recommendations for ammonia scavenger therapy:	
9-13	
0 g/m2/day of sodium phenylbutyrate and 3	
it is typically performed by age six months	
attention deficit/hyperactivity disorder (adhd)	
seizure disorders	C0014544//Epilepsy//MTH
learning disability/intellectual disability	
also see urea cycle disorders overview	
bleeding disorder	C0005779//Blood Coagulation Disorders//MTH	C1458140//Bleeding tendency//MTH
cardiac fibrosis	C1397307//Cardiac fibrosis//OMIM
pancreatectomy	C0030279//Pancreatectomy//MTH
issues to consider prior to referral for tpiat:	
the operation is irreversible	
pain relief is not universal	
chronic pancreatitis	C0149521//Pancreatitis, Chronic//MTH
cholecystokinin (cck) and its analogs (e	
, mineral oil, olestra), or	
, orlistat), or	
routine screening of patients with chronic pancreatitis for glucose intolerance	
esrd is treated with renal replacement therapy (i	
, dialysis and/or renal transplantation)	
registration or institutional access required)	
most are benign and can be completely excised	
preoperative	C0445204//Preoperative//MTH
a liberal sodium diet	
, 3 days prior to surgery)	
postoperative	C0032790//Postoperative Period//MTH
occupational, physical, and speech therapy are often helpful	
treatment focuses on symptomatic therapy	
feeding and nutrition	
no specific metabolic diet is recommended	
neurologic function	C0027767//Nervous System Physiological Phenomena//MSH
early intervention services should be provided	
seizures are present in approximately one third of affected individuals	
standard antiepileptic drugs (aeds) may be used	
no type of aed is contraindicated	
pch2	C1848526//Pontocerebellar Hypoplasia Type 2A//MTH	C2932714//Pontocerebellar Hypoplasia Type 2//MTH	C3890721//TRIP13 wt Allele//MTH
919g>t (p	
ala307ser)	
all other subtypes are very rare	
the main problems to manage:	
central visual impairment	C3810365//Central visual impairment//SNOMEDCT_US
epilepsy, which is amenable to standard treatments	
physiotherapy can be helpful	
pch4 and pch5	
respiratory support is usually given for a limited time	
palmoplantar keratoderma	C0022596//Palmoplantar Keratosis//MTH
however, trimming too aggressively can greatly increase pain	
topical therapies to remove the hyperkeratosis:	
occlusive ointments are often poorly tolerated	
nail dystrophy	C0221260//Dystrophia unguium//MTH
particularly troublesome nails can be successfully removed surgically	
oral leukokeratosis	C0023532//Leukoplakia, Oral//MTH
follicular hyperkeratosis	C0334013//Phrynoderma//SNOMEDCT_US
leukokeratosis with laryngeal involvement	
cysts	C0010709//Cyst//MTH
intralesional injection of steroid (e	
if necessary, cysts can be excised	
at present, no specific therapies can correct ciliary dysfunction	
, vigorous exercise)	
routine immunizations to protect against respiratory pathogens:	
pertussis	C0031237//Pertussis Vaccine//MTH	C0043167//Pertussis//MTH	C0043168//Whooping cough due to unspecified organism//MTH
haemophilus influenzae type b	C0121772//Haemophilus influenzae type b//MTH	C0475462//Haemophilus influenzae type B antigen//MTH
pneumococcal vaccine	C0358314//Pneumococcal vaccine//MTH	C2708140//Pneumococcal Vaccine:-:Point in time:^Patient:-//MTH
annual influenza virus vaccine	
this approach, however, is controversial	
nasal congestion and sinus infections	
chronic/recurrent ear infection	
male infertility	C0021364//Male infertility//MTH	C2048468//inability to impregnate//MTH
situs abnormalities	
special education programs should be offered	
, carbamazepine, phenytoin, valproate)	
hearing habilitation (hearing aids as early as possible)	
educational programs designed for individuals with hearing impairment	
provision should be made for any special educational needs	
estrogen can be administered orally or topically	
before considering pregnancy, uterine size should be assessed	
depression	C0011570//Mental Depression//MTH	C0011581//Depressive disorder//MTH	C0344315//Depressed mood//MTH	C0460137//Depression motion//MTH	C0812393//Cancer patients and suicide and depression//MTH	C1579931//Depressed - symptom//MTH	C1999266//Depression Adverse Event//MTH	C4049644//Depression Scale (BASC-2)//MTH	C4084909//Depression Subordinate Domain//MTH	C4085311//Depression - recess//MTH
weight loss	C1262477//Weight decreased//MTH	C2911645//Weight Loss Adverse Event//MTH	C4084774//Have Weight Loss//MTH	C4084775//Usual Severity Weight Loss//MTH	C4084776//How Often Weight Loss//MTH	C4084777//How Much Distress Weight Loss//MTH
additional management is symptomatic and expectant	
thoracic society 2000, american thoracic	
society & european respiratory society 2002]	
transplantation are good candidates	
five-year survival rates post transplant in	
non-pharmologic treatments:	
oxygen therapy may improve exercise tolerance in patients with	
hypoxemia	C0700292//Hypoxemia//MTH
pulmonary rehabilitation is a recommended option for patients who would	
benefit	C0814225//benefit//CHV
ipf	C0034069//Pulmonary Fibrosis//MTH	C1800706//Idiopathic Pulmonary Fibrosis//MTH
immunosuppressive/cytotoxic agents, and antifibrotic agents	
however, at least	
two antifibrotic pharmacologic interventions recently approved may be an option	
see therapies under	
investigation	C0220825//Evaluation//MTH	C1261322//Evaluation procedure//MTH	C1552578//Act Class - investigation//MTH
no management guidelines have been published	
the majority of individuals with pfcp require no regular treatment	
when symptoms of the hyperviscosity syndrome are evident	
hyperviscosity symptoms (see	
evaluations following initial diagnosis)	
grade 1	C0547053//First grade in elementary school//MTH	C0687695//Grade one rank//MTH	C1513302//Mild Adverse Event//MTH	C1883546//WHO Central Nervous System Grade I//MTH	C3889292//West Haven Hepatic Encephalopathy Grade 1//MTH	C4284290//Bayer Visual Acuity Changes Grade 1//MTH	C4284291//Simpson Grade 1//MTH	C4284292//Bayer Corneal Epitheliopathy Grade 1//MTH
grade 2	C0441802//Grade two rank//MTH	C0475270//G2 stage (tumor staging)//MTH	C0687696//Second grade in elementary school//MTH	C1513374//Moderate Adverse Event//MTH	C1522446//Disease Grade 2//MTH	C1883547//WHO Central Nervous System Grade II//MTH	C3889824//West Haven Hepatic Encephalopathy Grade 2//MTH	C4284293//Simpson Grade 2//MTH	C4284294//Bayer Visual Acuity Changes Grade 2//MTH	C4284295//Bayer Corneal Epitheliopathy Grade 2//MTH
in the presence of persistent symptoms perform phlebotomy	
grade 3	C0450094//Grade three rank//MTH	C0687697//Third grade in elementary school//MTH	C1519275//Grade 3 Severe Adverse Event//MTH	C1883548//WHO Central Nervous System Grade III//MTH	C3889290//West Haven Hepatic Encephalopathy Grade 3//MTH	C4283820//Simpson Grade 3//MTH	C4283821//Bayer Corneal Epitheliopathy Grade 3//MTH	C4283822//Bayer Visual Acuity Changes Grade 3//MTH
consider additional aspirin treatment	
thromboembolic events	C0040038//Thromboembolism//MTH
provide acute treatment according to established practice for the event	
evaluate for other thrombophilic risk factors	
consider additional aspirin treatment in all patients	
consider life-long anticoagulation (e	
pharmacologic therapy	C0013217//pharmacotherapeutic//MTH
nutritional therapy and supplementation	
nasogastric tube feeding has been useful in some infants	
other approaches	
interruption of the enterohepatic circulation of bile acids	
the internal biliary bypass approach of cholecystojejunocolic anastomosis	
liver transplantation (ltx)	
steatohepatitis can be progressive and lead to cirrhosis	
extrahepatic manifestations	
the general therapies for nephrolithiasis benefit all individuals with ph1	
patients should be advised to seek early medical attention	
alkalinzation of urine (ph 6	
2-6	
15 mg/kg or 0	
3-0	
treatment of kidney stones	
swl	
ureteroscopy	C0194261//Ureteroscopy//MTH	C0401276//Diagnostic endoscopic examination of ureter//MTH
percutaneous nephrolithotomy and ureteroscopy	
reduction of oxalate biosynthesis	
agt is a pyridoxal phosphate (plp)-dependent enzyme	
7 mmol/1	
phe152ile pathogenic allele	
73 m2/day)	
transplantation (tx) options:	
simultaneous liver - kidney	
sequential liver - kidney	
isolated kidney	
isolated liver	
hemodialysis (hd) strategy:	
perioperative ± postoperative based on pox & gfr	
preoperative & perioperative	
sometimes perioperative	
ckd category / residual gfr	
ckd category 3 (30<gfr<59)	
option in carefully selected patients	
ckd category 4 (15<gfr<29)	
option	C1518601//Options//MTH	C1550456//option - ActMoodPredicate//MTH
ckd category 5 (gfr <15)	
infantile form (esrd <2 yrs)	
use of deceased vs	
living donors for either or both organs	
, gfr >60 ml/min/1	
adequate fluid intake (>2	
5 l/m2 surface area/day)	
urinary inhibitors of calcium oxalate crystallization:	
potassium citrate (0	
maintainance of high oral fluid intake (>2	
5 l/m2 bsa)	
oral administration of an inhibitor of calcium oxalate crystallization	
avoidance of supersaturation of calcium oxalate in the blood	
avoidance of marked dietary oxalate excess	
simple avoidance of marked dietary oxalate excess is recommended	
metabolic abnormalities and hypertension generally improve within one week	
different thiazide diuretics exist, with different dosing regimens	
anal atresia or stenosis should be treated in standard fashion	
seizures are treated symptomatically	
repair of polydactyly should be undertaken on an elective basis	
if asymptomatic, observation alone is prudent	
when symptomatic, topical agents (e	
leg-length discrepancy secondary to segmental somatic overgrowth	
cardiac abnormalities (i	
, structural cardiovascular disease and arrhythmias)	
renal abnormalities	C4014891//Renal abnormalities//OMIM
speech, swallowing, and feeding difficulties	
neurologic and neurosurgical manifestations	
mcap syndrome	
hmeg	
somatic overgrowth, vascular, lymphatic and musculoskeletal manifestations	
infant feeding assessment to address early hypotonia as needed	
behavioral modification for self-injurious behavior or anxiety	
eyeglasses or surgery as needed for amblyopia	
orthopedic treatment of scoliosis as indicated	
standard care for other medical issues	
polyps	C0032584//polyps//MTH	C1546747//Specimen Source Codes - Polyps//MTH
this strategy has two goals:	
from st	
intussusception should be treated in a standard manner	
malignancies should be treated in a standard manner	
intramuscular botulinum toxin	
intrathecal and intraventricular baclofen	
ablative pallidotomy or thalmotomy	
referral for adaptive aids as needed (e	
, a walker or wheelchair for gait abnormalities)	
other manifestations	
treatment and interventions for retinopathy as per ophthalmology	
flank pain	C0016199//Flank Pain//MTH
cyst hemorrhage and gross hematuria	
nephrolithiasis	C0022650//Kidney Calculi//MTH	C0392525//Nephrolithiasis//MTH
5), and administration of allopurinol	
cyst infection	
cyst infection is often difficult to treat	
therapeutic agents of choice include trimethoprim-sulfamethoxazole and fluoroquinolones	
chloramphenicol has shown therapeutic efficacy in otherwise refractory disease	
end-stage renal disease (esrd)	
females appear to do better than males	
complications directly related to adpkd are rare	
polycystic liver disease	C0158683//Polycystic liver disease//MTH
and the results are often short-lived	
ruptured or symptomatic intracranial aneurysm	
asymptomatic aneurysms	
those aneurysms measuring 5	
if the size increases, surgery is indicated	
the management of aneurysms 6	
0-9	
0 mm in size remains controversial	
surgical intervention is usually indicated for aneurysms larger than 10	
aortic dissection	C0340643//Dissection of aorta//MTH
early recognition and treatment of dehydration is critical	
and (2) the risk for ascending cholangitis	
administration of synthetic bile acids	
portosystemic shunting may be necessary to treat progressive portal hypertension	
dual-organ transplantation	
see table 2 (pdf) and figure 1	
feeding and growth	
see acmg management guidelines for pku	
treatment of classic pku	
restriction of dietary phenylalanine	
maintain blood tyr in the normal range	
sapropterin (kuvan®)	
reviewed in ho & christodoulou [2014]	
large neutral amino acids (lnaa) transporters	
treatment for non-classic hyperphenylalaninemia	
neuropsychiatric testing may be considered to identify learning differences	
bone health assessment	
only symptomatic treatment is available	
epileptic seizures may worsen the individual's condition	
those with severe dysphagia may require feeding by gastrostomy	
response to pharmacologic treatment is poor	
however, clonazepam or diazepam can be effective	
no disease-modifying drug treatment exists for pnpla6-related disorders	
speech therapy [sapir et al 2003]	
swallowing therapy	C0589274//Swallowing promotion therapy//SNOMEDCT_US
assistive walking devices and ankle-foot orthotics	
, baclofen [oral or intrathecal], tolperison	
botox® injections) and urinary urgency (e	
hypothyroidism is treated with thyroid hormone replacement (e	
, levothyroxine) at the time of diagnosis	
dysphagia management is therefore important	
hypersalivation is managed with the multidisciplinary team and an otolaryngologist	
treatment must be individualized	
therapies to consider include rehabilitation (e	
, oromotor therapy, behavioral therapy)	
medical therapy (e	
, anticholinergic medications, botulinum toxin injections)	
and, in severe cases, surgery (e	
learning difficulties are likely to progress slowly	
patients should be followed regularly by an endocrinologist	
patients need to be followed regularly by an ophthalmologist	
the following treatment is recommended:	
speech therapy for those with language impairment	
occupational therapy for those with language impairment	
severe obesity	C0028756//Obesity, Morbid//MSH
therefore, lifestyle measures should be instigated	
fair skin	C1849923//Generalized hypopigmentation//MTH	C1858570//Fair Skin//MTH
growth hormone (gh) deficiency	
treatment is highly effective	
iron reduction	
iron chelation therapy (e	
serum ferritin concentration should be measured before starting phlebotomy treatment	
for persons with the hfe genotypes p	
cys282tyr or p	
low-dose anti-malarial agents	
combining both treatment modalities (i	
pct may also improve after treatment of coexisting hepatitis c	
pct should be treated first in most individuals:	
neurovisceral symptoms	
most acute neurovisceral attacks require hospital admission	
harmful medications should be discontinued	
cutaneous symptoms	
patients should wear protective clothing and avoid exposure to sunlight	
topical steroids are of little or no benefit	
strabismus and/or refractive errors	
standard treatment as recommended by ophthalmologist	
dental crowding / malocclusion	
evidence of sleep apnea	
standard treatment as indicated	
diet diary & calorie counts may be requested	
hypoglycemia, short stature, evidence of growth hormone deficiency	
standard treatment(s) as recommended by endocrinologist	
standard treatment as recommended by cardiologist	
renal anomaly and/or vesicoureteral reflux	
standard treatment as recommended by nephrologist/urologist	
enrollment in dda (developmental disabilities administration) is recommended	
, scoliosis)	
consider:	
evaluation for alternative means of communication (e	
pleuropulmonary blastoma (ppb)	
individuals receiving neoadjuvant chemotherapy may have marked tumor reduction	
chemotherapy alone is insufficient to eradicate solid ppb	
pleural effusions	C0032227//Pleural effusion disorder//MTH
drainage of pleural effusions should be approached with caution	
surgery for metastases	
therapeutic resection of bone and liver metastases is rarely indicated	
type i ppb	
types ii and iii ppb	
aggressive chemotherapy is necessary	
ppbregistry	
radiation therapy	C0034619//radiotherapeutic//MTH	C1522449//Therapeutic radiology procedure//MTH	C1578499//Diagnostic Service Section ID - Radiation Therapy//MTH
treatment failure	C0162643//treatment failure//MTH	C0235828//Lack of Efficacy//MTH	C0521983//Absence of therapeutic response//MTH	C1547544//Charge Type Reason - Treatment Failure//MTH
ovarian sex cord-stromal tumors	
sertoli-leydig cell tumor	C0206723//Sertoli-Leydig Cell Tumor//MTH	C1318541//Sertoli-Leydig cell tumor of intermediate differentiation//MTH
juvenile granulosa cell tumor (jgct)	
hyperthermic chemotherapy has been used by some investigators	
gynandroblastoma	C0018413//Gynandroblastoma//MSH	C0206722//Neoplasms, Gonadal Tissue//MSH
the malignant potential of gynandroblastoma is not yet clear	
cystic nephroma	C1266138//Benign cystic nephroma//SNOMEDCT_US
multinodular goiter (mng) and thyroid cancer	
observation with or without biopsy	
ciliary body medulloepithelioma (cbme)	
the four management options include:	
observation	C0302523//Observation in research//MTH	C0478530//Examination and observation for unspecified reason//MTH	C0700325//Patient observation//MTH	C0941132//Organ finding//MTHMST	C1548358//Specialty Type - Observation//MTH	C1554188//act - observation//MTH	C1964257//Observation - diagnostic procedure//MTH
local resection	C0278259//Local excision//SNOMEDCT_US
however, many of these tumors will progress	
enucleation	C0014392//Enucleation procedure//MTH	C1526987//cellular enucleation//MTH
long-term survival is common after this definitive therapy	
orbital exenteration	C0162661//Orbit Evisceration//MSH
nasal chondromesenchymal hamartoma (ncmh)	
however, complete extirpation is preferred	
pituitary blastoma	
pineoblastoma	C0031941//Pineal Gland Neoplasm//MTH	C0205898//pineoblastoma//MTH
immediate management issues may include interventions for obstructive hydrocephalus	
an aggressive surgical approach is associated with prolonged survival	
medications in use for pah include the following:	
endothelin blockers (oral)bosentanambrisenanmacitentan	
phosphodiesterase inhibitors (oral)sildenafiltadalafil	
guanylate cyclase stimulator (oral)riociguat	
calcium channel blockers	C0006684//Calcium Channel Blockers//MTH	C2757014//Calcium Channel Antagonists [MoA]//MTH
adjunctive agents	
mean survival after lung transplantation is about five years	
no specific therapy for ppd is available	
pain due to secondary osteoarthritis may respond to nsaids	
physical therapy may help preserve joint mobility	
immobilization (e	
, casting) should be avoided	
angular deformities of lower limbs	
progressive joint stiffness	
, hip and knee replacement)	
progressive stiffness and deformities of the spine	
scoliosis and mild kyphosis can be managed with bracing	
therapy is aimed at controlling symptoms that may cause discomfort	
myoclonus can sometimes be mitigated by clonazepam	
issues related to dysphagia are often difficult to resolve	
no curative treatment is available	
care is preferably provided by a multidisciplinary team	
growth hormone	C0037663//Growth Hormone//MTH	C0169964//Somatropin//MTH	C0202056//Growth hormone measurement//MTH	C1753283//growth hormone activity//MTH	C3714500//Human Growth Hormone//MTH
, recombinant) gh	
tsh	C0040160//Thyrotropin//MTH	C0202230//Thyroid stimulating hormone measurement//MTH
lh and fsh	
usually sex steroids are used to maintain secondary sex characteristics	
acth	C0001655//Corticotropin//MTH	C0201835//Adrenocorticotropic hormone measurement//MTH	C1337111//POMC gene//MTH	C1523997//Recombinant Corticotropin//MTH	C1704793//POMC wt Allele//MTH	C3539087//ACTH and synthetic analog preparations//MTH	C3818725//corticotropin, human//MTH
neonatal/acute decompensation	
in-patient management	
assess and manage ventilation and circulation as necessary	
determine the need for sepsis workup and antibiotics	
reverse catabolism by giving intravenous glucose and lipids	
dextrose solutions exceeding the concentration of 12	
5% require a central line placement	
additional calories can be provided using parenteral lipid emulsion	
manage protein intake to reduce propiogenic precursors	
remove toxic compounds	
pharmacologic detoxification:	
oral n-carbamoylglutamate (carglumic acid	
manage pancreatitis using standard practices	
home management of metabolic status	
at-home detection and monitoring of urine ketones	
diet modification under the direction of the metabolic team	
management of arrhythmias is similar to that from other causes	
dermatologic manifestations (e	
evaluation for dvts	
evaluation of pe	
bullous pulmonary disease	
psychosocial issues	C1519391//Social Aspects of Cancer//NCI
0 mg/dl (360 μmol/l)	
febuxostat, a newer urate-lowering xanthine oxidase inhibitor	
note: excretion of >1	
high daily fluid intake (i	
, ≥2 l/day in the adult)	
xanthinuria does not respond to urinary alkalinization	
several expert groups (e	
giessen, germany)	
burtonsville, md)	
cholecystokinin (cck) and its analogues (e	
13c-mixed triglyceride breath test	
72-hour fecal fat	
sudan stain	C1282434//Sudan stain//SNOMEDCT_US
, mineral oil, olestra)	
, orlistat)	
chronic pancreatitis is associated with a gradual loss of function	
surgical methods are standard	
a target inr of 2	
5 (therapeutic range: 2	
anticoagulation is recommended:	
indefinitely for those with recurrent idiopathic vte	
cognitive/developmental delay	
see global developmental disability/ intellectual disability educational issues	
management by a neurologist	
, dystonia, dyskinesia, dysconjugate eye movements)	
vision deficits	
correction of refractive errors	
vision support	
standard treatment for strabismus & exophoria	
supplementary oxygen (at night) & rarely tracheostomy	
ambulatory peripheral saturation monitoring may be required	
congenital heart defect	C0018798//Congenital Heart Defects//MTH
frequent aspiration (or high risk of aspiration)	
a percutaneous endoscopic gastrostomy tube may be considered	
medical management	
referral to a gastroenterologist may be required in severe cases	
congenital urogenital defect	
management as per current practice for the specific urogenital defect	
progressive neuropathic scoliosis may require spinal fusion	
osteoporosis/osteopenia	
instability in standing position	
neuropathic hip dysplasia, progressive subluxation, & dislocation	
consideration of hip reconstructions w/varus derotational proximal femoral osteotomies	
vitamin d deficiency	C0042870//Vitamin D Deficiency//MTH
vitamin d supplementation	
anterior pituitary hormone deficiencies	
standard treatment as directed by an endocrinologist	
global developmental disability/ intellectual disability educational issues	
, scoliosis, hip dislocation)	
, feeding, grooming, dressing)	
feeding, hyperphagia, and obesity	
therapies, education and behavior management	
initiate appropriate educational programming in children:	
social skills training groups have been beneficial	
however, preservation of fertility is not an issue	
standard treatment is appropriate	
angulo & miller, unpublished data]	
schulze et al 2001	
vats & cassidy, unpublished data]	
sleep issues	
skin picking	
management of strabismus is as for any infant	
adulthood	C0700597//Adulthood//MTH
affected individuals generally require a sheltered employment environment	
no specific treatment for pxe exists	
for all phenotypes	
occupational therapy to maximize motor function	
speech therapy for dysarthria	
rdp	C1414134//DPEP1 gene//MTH	C1422315//NELFE gene//MTH	C1868681//DYSTONIA 12//MTH
standard therapies for the following are appropriate:	
ahc	C0220766//Congenital hypoplasia of adrenal gland//MTH	C2698419//NR0B1 wt Allele//MTH
episode prophylaxis (avoiding triggers	
prophylactic medications	
flunarizine	C0016295//Flunarizine//MSH
chloral hydrate	C0008161//Chloral Hydrate//MTH
other sleep inducers	
epilepsy management utilizes existing anticonvulsants	
capos syndrome	C1832466//CAPOS syndrome//MSH
symptomatic treatment includes hearing and visual aids	
capillary malformations (cms)	
avms/avfs	
, embolization vs	
surgery)	
cardiac overload	C0684338//heart overload//AOD
hemihyperplasia and/or leg length discrepancy	
lymphangiography to evaluate for lymphatic malformations may be considered	
prostheses	C0175649//Prosthesis//MTH
intervention and/or special education if developmental delays are detected	
cataract extraction may preserve some vision	
orthopedic procedures have improved function in some individuals	
dietary restriction of phytanic acid intake	
avoidance of sudden weight loss	
lifelong treatment with hydrating creams	
treatment of acute presentation	
treatment options for the eye include enucleation	
cryotherapy	C0010408//Cryosurgery//MTH	C0010412//Cold Therapy//MTH
radiation therapy using episcleral plaques	
legal use of telescopic lenses may vary by locale	
retinoschisis affects primarily the inner retinal layers	
psychosocial support for families is an integral part of management	
they are tolerated better than milk of magnesia	
high dose supplementation	
supportive care	C0344211//Supportive care//MTH
respiratory support	
physiotherapy to avoid contractures	
occupational therapy for support in activities of daily living	
orthotics for limb and trunk bracing	
speech and language therapy to avoid choking and respiratory problems	
wheel chair as needed	
low vision aids for those with decreased visual acuity	
routine management of scoliosis to avoid long term respiratory problems	
routine management of depression	
pharmacologic treatment focuses on improving pain and correcting bone deformation	
low dose	C0445550//Low dose//SNOMEDCT_US
high dose	C0444956//High dose//SNOMEDCT_US
50 to 0	
75 µg daily	
in these individuals, surgical treatment is frequently pursued	
the literature consists of case series	
craniofacial treatment	
sensorineural hearing loss has been reported in persons with xlh	
see hereditary hearing loss and deafness overview, management	
corrective surgeries may be required for repair of:	
abnormal penile insertion/penoscrotal position	
hormone therapy may be helpful for males with micropenis	
orthodontic treatment is typically required	
corrective surgeries may be required for the following:	
syndactyly repair	
severe scoliosis secondary to hemivertebrae and rib abnormalities	
cleft lip and cleft palate repair	
hormone therapy should be monitored by a pediatric endocrinologist	
orthodontic treatment is usually required	
no treatment is required	
cystoid macular edema (cme)	
optical aids	C0871011//Optical Aids//PSY
however, its current cost limits widespread use	
retinal prostheses	C2936198//Visual Prosthesis//MSH
agencies for the visually impaired	
general management guidelines for those with systemic involvement:	
nutritional support (e	
management may include consideration of tracheostomy and artificial ventilation	
referral to a pediatric neurologist for seizure management	
of note, seizures may be refractory to treatment	
aggressive management of fever and infection	
5 epimutations possibly because children with 11p15	
initial treatment is use of a shoe lift	
neurodevelopment	C0599855//neurodevelopment//CHV
gastrointestinal disorders should be aggressively managed	
craniofacial anomalies	C0376634//Craniofacial Abnormalities//MSH
orthognathic surgery is rarely required	
referral of males with cryptorchidism to a urologist	
referral of males with micropenis to an endocrinologist	
androgenic hormone therapy as indicated	
neoplasia	C0027651//Neoplasms//MTH	C1882062//Neoplastic disease//MTH
standard treatment for hearing loss if identified	
standard treatment for cardiac defects if identified	
aggressive management of gastroesophageal reflux and constipation	
standard treatment for cryptorchidism if identified	
surgical repair of significantly angulated thumbs or duplicated halluces	
appropriate treatment for sleep apnea if identified	
visually significant cataracts require surgical removal	
complete cessation of symptoms is the goal	
it is therefore important that:	
adequate posture should be maintained when lying prone and sitting	
hematologic manifestations	
treatment is symptomatic:	
sensory axonal neuropathy	C1842587//Sensory axonal neuropathy//HPO
physiotherapy and orthoses to prevent foot and spine deformity	
supportive shoes, splints, and braces	
foot care to treat calluses and ulcerations	
a walker, wheelchair, physiotherapy, occupational therapy	
some patients have benefited from lamotrigine or levetiracetam	
psychiatric symptoms	C0233401//Psychiatric symptom//MTH
canes and walkers help prevent falling	
occupational therapy, including home adaptations	
physiotherapy and assessment for cane and wheelchair	
ankle-foot orthotics (afos) for those with neuropathy	
modest success has been observed in some affected individuals	
supplements of antioxidants, which may have some beneficial effects	
treatment of psychiatric syndromes as needed	
technical assistance with writing and other fine-motor tasks	
epileptic seizures can be improved by treatment with anticonvulsive medications	
treatment of seizures with antiepileptic drugs (aeds)	
treatment of dystonia with local injections of botulinum toxin	
at present, only symptomatic treatments are available	
these include the following:	
crutches (less often canes) and walkers	
speech/language therapy for dysarthria and swallowing difficulties	
surgical intervention as needed for severe ptosis	
symptoms of restless legs syndrome may respond to these agents	
non-pharmacologic therapy is important in sca3:	
specific treatment for sca36 is currently not available	
walking aids to facilitate ambulation and mobility	
the use of a wheelchair is rare	
speech therapy and communication devices for those with dysarthria	
the utility of cochlear implants in sca36 is unknown	
vestibular suppressants may reduce vertigo and/or osscilopsia	
canes, walking sticks, and walkers help prevent falling	
note: rbd is rare in individuals with sca6	
continuous positive airway pressure may be used for sleep apnea	
cerebellar ataxia	C0007758//Cerebellar Ataxia//MTH
retinal degeneration	C0035304//Retinal Degeneration//MSH
use of canes and walkers helps prevent falls	
compound heterozygous for pathogenic variant and a susceptibility variant	
free carnitine levels were normal in all individuals	
no published treatment guidelines exist	
, dravet syndrome	
see scn1a-related seizure disorders and differential diagnosis)	
sodium channel blockers	C0872271//Sodium Channel Blockers//MTH	C2936807//Sodium Channel Antagonists [MoA]//MTH
other aeds	
vagus nerve stimulator	C2959478//Vagal nerve stimulator//SNOMEDCT_US
cannabinoids	C0006864//Cannabinoids//MTH	C0202349//Cannabinoids measurement//MTH	C2347556//nabiximols//MTH	C2698976//Cannabinoid Drug Class Measurement//MTH
sleep hygiene	C4277672//Sleep Hygiene//MSH
it prevents the following:	
in most cases, cranioplasty precedes palatal repair	
ophthalmologic abnormalities are treated in a standard fashion	
routine monitoring (see surveillance) is recommended	
hematologic abnormalities	
prompt treatment of hypoglycemia if present	
ophthalmologist for management of vision problems	
neurologist if seizures are present	
oncologist if a tumor is identified	
surgical intervention for aneurysms may be indicated	
surgical repair of abdominal hernias may be indicated	
cleft palate and craniosynostosis require management by a craniofacial team	
surgical fixation of cervical spine instability may be necessary	
clubfoot deformity may require surgical correction	
pectus excavatum may be severe	
rarely, surgical correction is indicated for medical reasons	
physiotherapy	C0699718//Physical therapy (field)//MTH	C0949766//Physical therapy//MTH
physiotherapy may help increase mobility in individuals with joint contractures	
axenfeld-rieger anomaly or related anterior chamber ocular anomalies	
dental anomalies	C0262444//Abnormality of the dentition//MTH
insulin resistance/diabetes mellitus	
a systematic approach to pain management should be reviewed regularly	
vaso-occlusive pain episodes (including dactylitis)	
, cold, dehydration)	
nsaids (e	
fever/suspected infection	
individuals with temperature greater than 38	
rapid triage and physical assessment	
urgent cbc and reticulocyte count	
acute chest syndrome (acs)	
perform chest x-ray examination	
incentive spirometry should be encouraged	
aplastic crisis	C0302111//Aplastic crisis//SNOMEDCT_US
blood transfusion may be necessary	
splenic sequestration	C1260402//Splenic sequestration//MDR
pulmonary hypertension	C0020542//Pulmonary Hypertension//MTH	C1963220//Pulmonary Hypertension Adverse Event//MTH
the following general approach is reasonable:	
, thrombotic disease, obstructive sleep apnea)	
optimization of scd-related therapy to stop progression (e	
stroke	C0038454//Cerebrovascular accident//MTH
cerebral hemorrhage requires immediate neurosurgical consultation	
chronic transfusion has been shown to reduce silent infarcts	
priapism	C0033117//Priapism//MSH
there is no effective treatment for xlsa/a	
weighted eating utensils may help promote independent skills in childhood	
speech therapy may improve intelligibility problems resulting from dysarthria	
hepatic and systemic iron overload does not occur	
orthopedic manifestations	
treatment of scoliosis and/or kyphosis is standard	
immunologic manifestations	
individuals with autoimmune problems have had variable responses to treatment	
infectious disease manifestations	
hypothyroidism can be treated with levothyroxine supplementation	
chelation therapy	C0007975//Chelation Therapy//MSH
monitoring includes the following:	
complete blood count	C0009555//Complete Blood Count//MTH
assessment of liver function	
assessment of iron status	
treatment may need to be discontinued if:	
white blood count is <3	
5x109/l	
neutrophil count is <2	
0x109/l	
platelet count is <150x109/l	
although the role of atypical tranquilizers (e	
treatment of status dystonicus	
standard protocols are used in an intensive care setting	
cholesterol supplementation	
dental management can be challenging	
recurrent otitis media may require tympanostomy tube placement	
see spinal muscular atrophy	
feeding/growth	
manage gastroesophageal reflux disorder in the standard manner	
use oral suctioning as needed	
in some cases artificial ventilation and tracheostomy may be employed	
manage accordingly	
health issues specific to sma	
scoliosis occurs frequently in individuals with sma ii	
no surgical complications were identified	
hip dislocation is another orthopedic concern in sma	
ongoing pediatric care with regular immunizations	
[hildenbrand & smith 2012]	
no well-controlled treatment trials have been reported:	
thus, dosages may not be exact	
enclosed bed system for containment during sleep	
treatment with diet or medication as indicated	
treatment with corrective lenses as indicated for ophthalmologic abnormalities	
treatment of recurrent otitis media with tympanostomy tubes as needed	
the bones in sclerosteosis are thick and dense	
surgical intervention may be difficult and prolonged	
standard neurosurgical instruments may not be sufficient (i	
tooth extraction may be difficult	
management by an orthodontic or craniofacial team is recommended	
when clinical problems (e	
care includes:	
early referral to an experienced multidisciplinary team	
referral to special educational services for visually impaired infants	
referral to endocrinologist for growth or hypogonadism concerns	
referral to physiotherapist if any evidence of motor impairment exists	
referral to special educational services for neurodevelopmental problems as needed	
parent/caregiver training in seizure management	
no specific drug treatment or cures exist for spg11	
physiotherapy for stretching of the spastic muscles to prevent contractures	
anti-spastic drugs such as baclofen and tizanidine	
anticholinergic drugs are indicated for urinary urgency	
psychiatric manifestations should be treated in accordance with standard practice	
physiotherapy is appropriate	
foot deformities are corrected by surgical treatment	
improve muscle strength (through resistance exercise)	
improve cardiovascular fitness	
oxybutynin is helpful in reducing urinary urgency	
see also hereditary spastic paraplegia overview	
spasticity can be treated with:	
oral baclofen or tizanidine	
chemodenervation with botulinum a or b toxins	
intrathecal baclofen pump	C3836732//intrathecal baclofen pump//MEDCIN
see also prevention of secondary complications	
referral to orthotic services may be helpful	
urinary urgency can be treated with anticholinergic antispasmodic drugs	
symptomatic treatment includes use of the following:	
antispastic drugs for leg spasticity	
anticholinergic antispasmodic drugs for urinary urgency	
regular physiotherapy for stretching of spastic muscles	
no specific drug treatments or cures exist for spg7	
antispasmodic drugs (e	
no significant toxicity limits their use	
routine treatment of inguinal herniae	
surgical intervention as needed if scoliosis is significant	
l-dopa (0	
optimal therapeutic level is determined by clinical response	
tetrahydrobiopterin (bh4	
monoamine oxidase inhibitors (selegeline)	
serotonin reuptake inhibitors (sertraline)	
melatonin	C0025219//Melatonin//MTH	C1295184//Melatonin Measurement//MTH	C1527137//Recombinant melatonin//MTH
dopamine agonists (bromocriptine, pramipexole)	
anticholinergics	C0242896//Anticholinergic Agents//MTH	C3537307//Anticholinergics inhalants for obstructive airway diseases//MTH	C3540711//Anticholinergic mydriatics and cycloplegics//MTH
methylphenidate	C0025810//Methylphenidate//MTH	C0524188//Methylphenidate measurement//MTH
5 years [escalera et al 2010]	
and speech therapy [gropman 2003]	
refractive errors should be corrected with spectacles	
myringotomy tubes are often required	
some of these treatments have only been partially effective	
current treatment therapies focus on the following:	
treatments should begin at the time of diagnosis	
often existing xanthomas regress	
partial ileal bypass surgery (i	
sitosterolemia does not respond to standard statin treatment	
global developmental delay, cognitive dysfunction and intellectual disability	
seizure management is symptomatic	
other neurologic findings	
bracing for scoliosis and kyphosis	
blepharoplasty for significant ptosis	
hearing aids and/or cochlear implantation for sensorineural hearing loss	
agents such as gabapentin should be considered	
gentle handling may reduce pain that is worsened with movement	
splinting of affected joints may provide comfort	
consultation with a pain management specialist may be helpful	
palliative care may be an option in severe cases	
a nutritionist should follow affected individuals	
protein-losing enteropathy	C0033680//Protein-Losing Enteropathies//MTH
an effective long-term treatment is lacking	
dermatitis	C0011603//Dermatitis//MTH
perianal masses may be excised, but may recur	
contractures are typically progressive	
immune system/infections	
the treatment for thrombocytopenia is platelet transfusion as needed	
but the clinical response is unpredictable and generally poor	
the management of epilepsy in many genetic epilepsies is complex	
refer to an urologist or nephrologist as indicated	
manage according to the anomalies detected	
imperforate anus	C0003466//Anus, Imperforate//MSH
immediate surgical intervention is required	
thumb malformations	
, removal of additional thumbs)	
birth to 2 years: airway and feeding difficulties	
13 years to 18 years: orthognathic surgery	
generally, bone reconstruction precedes soft tissue corrections	
reconstruction can prevent the progression of facial asymmetry	
maxillomandibular reconstruction	
orthognathic procedures are typically indicated before age 16 years	
misaligned teeth often require orthodonture	
nasal reconstruction, if needed, should follow orthognathic surgeries	
other measures:	
medication to control seizures, as in the general population	
shunt placement, when hydrocephaly is identified	
suboccipital decompression for relief of craniocervical junction constriction	
hearing aids, when hearing loss is identified	
supplemental oxygen should be administered as needed	
other individualized ambulatory devices may be indicated	
carpal tunnel release surgery for carpal tunnel syndrome	
vitrectomy for vitreous involvement	
therapeutic phlebotomy	C0005857//Bloodletting//MTH
periodic phlebotomy (i	
the usual therapy is weekly phlebotomy	
camaschella & roetto, unpublished observation]	
treatment of clinical complications	
in some cases, joint replacement has been performed	
diabetes mellitus may require lifelong insulin treatment	
glycopyrolate or scopolamine to improve drooling	
standard anticonvulsant medication to control seizures, if present	
placement of permanent feeding tube to avert malnutrition	
see also therapies under investigation	
, 0	
mild form (th-deficient drd)	
individuals demonstrate complete responsiveness of symptoms to levodopa treatment	
individuals show a marked response to levodopa	
very severe form (th-deficient progressive infantile encephalopathy)	
individuals are extremely sensitive to levodopa	
2 to 1	
long qt interval	
beta-blockers	C0001645//Adrenergic beta-Antagonists//MTH
pacemaker	C0030163//Artificial cardiac pacemaker//MTH	C1546728//Specimen Source Codes - Pacemaker//MTH	C3275122//Pacemaker Procedure//MTH	C3853703//Pacemaker ECG Assessment//MTH
implants	C0021102//Implants//MTH	C2926601//Procedure implants:Finding:Point in time:^Patient:Narrative//MTH
respiratory infections	C0035243//Respiratory Tract Infections//MSH
the possibility of reduced immune response should be considered	
surgical release of syndactyly	
currently there is no definitive treatment	
management should involve a multidisciplinary team	
management of trps is principally supportive	
ectodermal features	
hair	C0018494//Hair//MTH	C0444095//Hair Specimen//MTH	C1546660//Hair Specimen Code//MTH
however, reported results vary	
hands	C0018563//Hand//MTH
regular simple analgesia (e	
physiotherapy may aid mobility	
for trps ii only	
exostoses	C0015302//External exotoses//MTH	C1442903//Exostoses//MTH
restriction of dietary trimethylamine and its precursors	
choline	C0008405//Choline//MTH
dietary choline is absorbed through the small intestine	
trimethylamine n-oxide	C0077194//trimethyloxamine//MSH
intake of such vegetables should be restricted	
use of acid soaps and body lotions	
trimethylamine is a strong base (pka 9	
thus, at ph 6	
0, less than 0	
02% of trimethylamine exists as the volatile free base	
sequestering of trimethylamine produced in the gut	
suppression of intestinal production of trimethylamine	
enhancement of residual fmo3 enzyme activity	
counseling	C0010210//Counseling//MTH	C0740209//Encounter due to counseling//MTH	C2148587//duration of encounter - counseling (___ min)//MTH
affected individuals and their families benefit from counseling	
see table 3	
dental crowding /	
malocclusion	C0024636//Malocclusion//MTH
dietary diary & calorie counts may be requested	
gerd and/or constipation	
standard treatment(s)	
standard treatment(s) as recommended by neurologist	
scoliosis / kyphosis	
standard treatment as recommended by orthopedist	
effectiveness should be evaluated on an individual basis	
high-dose thiamine supplementation:	
invariably improves the hematologic picture	
additional treatment	
red blood cell transfusion for severe anemia is indicated	
treatment has included cochlear implant [hagr 2014]	
in some instances intrathecal baclofen pumps can be considered	
dystonia can be managed with:	
baclofen or intramuscular botulinum toxin when associated with spasticity	
trihexyphenidyl or tetrabenazine	
dysarthria may warrant augmentative communication tools	
anticonvulsant medications should be used when seizures are present	
subependymal giant cell astrocytomas (segas)	
additional trials are underway to confirm these preliminary findings	
renal angiomyolipoma	C0241961//Angiomyolipoma of kidney//MTH
facial angiofibromas	C0265319//Fibrous skin tumor of tuberous sclerosis//MTH
cardiac rhabdomyomas	
, outflow tract obstruction) was surgery	
however, response to treatment is highly individual	
oxygen therapy is necessary with impaired lung function	
persons with severe disease require lung transplantation	
management guidelines have been published	
acute management of liver failure	
nitisinone (orfadin®)	
nitisinone is generally prescribed at 1	
0 mg/kg/day	
individual requirements may vary	
nitisinone is typically given in two divided doses	
low-tyrosine diet	
3 mg/dl)	
transplant recipients require long-term immunosuppression	
transplant recipients may also benefit from low-dose (0	
ocular abnormalities (nystagmus/strabismus)	
ophthalmologic management	
oral feeding difficulties	
g-tube feeding	
braces and/or corrective surgery	
self-injurious behavior	C0085271//Self-Injurious Behavior//MTH
behavior modification therapy	C2065025//behavior modification therapy//MEDCIN
hypo/hypertonia, gross motor delays, sensory processing difficulties	
physical therapy, occupational therapy	
absent speech	C1854882//Absent speech//HPO
sign language instruction	
consider alternate forms of communication	
urinary tract	C0042027//Urinary tract//MTH	C1508753//Urinary system//MTH
urinary tract infections warrant rapid and complete treatment	
antibiotic prophylaxis may also be considered	
bowel	C0021853//Intestines//MTH	C4083257//Pattern of Bowel Movements Question//MTH
constipation is managed as for the general population	
balance	C0014653//Equilibrium//MTH	C0179199//Balance, device//MTH	C0205415//Balanced - adjective//MTH	C0560184//Ability to balance//MTH	C2174421//examination of balance//MTH	C4319618//Balance (substance)//MTH
hearing aids are helpful	
environmental trauma (e	
, noise) or a genetic susceptibility (e	
in such individuals, cochlear implantation may be warranted	
no guidelines exist for the management of vhl lesions	
cns hemangioblastoma	C1333955//Central Nervous System Hemangioblastoma//NCI
two patients required additional surgery	
retinal hemangioblastoma	C1514915//Retinal hemangioblastoma//HPO
renal cell carcinoma	C0007134//Renal Cell Carcinoma//MTH	C2984311//Renal Cell Carcinoma Pathway//MTH	C3540608//NCI CTEP SDC Renal Cell Carcinoma Sub-Category Terminology//MTH
3% and 4	
3%, respectively [young et al 2012]	
pheochromocytomas	C0031511//Pheochromocytoma//MTH
pheochromocytomas should be surgically removed	
laparoscopic approaches have been shown to be effective	
partial adrenalectomy could be considered	
one long-term follow-up study (9	
partial adrenalectomy is also therapy of choice in children	
in 10 vhl patients 18 successful operations were performed	
after follow up (median 7	
pancreatic cysts and neuroendocrine tumors	
a tumor of ≥3 cm	
a pathogenic variant in exon 3	
a tumor with a doubling rate <500 days	
endolymphatic sac tumors (elst)	
twenty-nine patients were symptomatic	
epididymal or broad ligament papillary cyst adenomas	
physical therapy to promote ambulation	
treatment is required for any symptomatic vmcm lesion	
an appropriate dose is 0	
625 ml/kg) or 150 mg/m2 (3	
75 ml/m2)	
desmopressin	C0011701//desmopressin//MTH
intranasal preparations are also available	
intravenous infusion of vwf/fviii clotting factor concentrates	
in those who are non-responsive to desmopressin (i	
virus inactivation procedures eliminate potential pathogens	
indirect treatments	
fibrinolytic inhibitors (i	
hormonal treatments (i	
treatment by vwd type	
type 1 vwd	
treatments that directly increase vwf levels (e	
indirect treatment with fibrinolytic inhibitors or hormones is often effective	
type 2a vwd	
indirect treatments can be beneficial	
type 2b vwd	
[federici et al 2009]	
indirect treatments (i	
, fibrinolytic inhibitors) can be useful	
type 2m vwd	
type 2n vwd	
type 3 vwd	C1264041//von Willebrand Disease, Type 3//MSH
desmopressin is not effective in type 3 vwd	
indirect treatments may also be beneficial	
vwf levels are higher in the neonatal period	
pharmacotherapy	C0013216//Pharmacotherapy//MTH	C0013217//pharmacotherapeutic//MTH
to reduce or delay side effects (e	
patients treated with ergot-derived dopamine agonists require periodic echocardiograms	
droxidopa may be used to treat orthostasis	
click here for full text	
management is supportive/symptomatic	
cleft lip	C0008924//Cleft upper lip//MTH	C4321245//Cleft lip or lips//MTH
management is surgical, dental, and orthodontic	
lip pits	C0266092//Congenital lip pits//MTH	C0341059//Lip pit//MTH
popliteal pterygium	C3805420//Popliteal pterygium//HPO
syndactyly may require surgery	
the genital anomalies may result in infertility	
refractive error is corrected by spectacles or contact lenses	
visually disabling cataract is treated by cataract surgery	
wiskott-aldrich syndrome	C0043194//Wiskott-Aldrich Syndrome//MTH	C1421478//WAS gene//MTH
[buchbinder et al 2014]	
hematopoietic cell transplantation (hct)	
eczema	C0013595//Eczema//MTH
topical steroids are the mainstay of therapy	
autoimmune disease	C0004364//Autoimmune Diseases//MTH
x-linked thrombocytopenia (xlt)	
, risk of secondary malignancy, infertility)	
x-linked neutropenia (xln)	
camptodactyly	C0221369//Acquired Camptodactyly//MTH	C0685409//Congenital Camptodactyly//MTH
occasionally toe camptodactyly may require surgical intervention	
physiotherapy may also be beneficial	
ligamentous laxity	C0086437//Joint laxity//MTH	C0158359//Laxity of ligament//MTH
control of type 2 diabetes mellitus	
use of cholesterol-lowering drugs if lipid profile is abnormal	
muscle atrophy is a potential complication	
surgical treatment of ocular cataracts	
treatment of malignancies in a standard fashion	
treatment follows routine practices for insulin-dependent diabetes mellitus	
wfs	C0043207//Wolfram Syndrome//MTH	C1421501//WFS1 gene//MTH
low-frequency sensorineural hearing loss (lfsnhl)	
psychiatric difficulties	
neurogenic bladder	C0005697//Neurogenic Urinary Bladder//MTH
treatment of central diabetes insipidus follows routine practices	
treatment of gastroparesis and celiac disease follows routine practices	
(see celiac disease	
sleeping problems	
if no medical factors (e	
hepatic adenomas	
other structural anomalies (e	
cognitive/behavioral	
self-calming techniques can help manage anxiety	
hypertension is usually treated medically	
hypercalcemia	C0020437//Hypercalcemia//MSH
management of hypercalcemia involves the following:	
hydration status should be assessed	
increase water intake as indicated	
but the serum concentration of calcium must be monitored	
vitamin supplements containing vitamin d should be avoided	
refractory hypercalcemia may be treated with oral steroids	
eye, ear, nose, and throat	
hyperopia is treated with corrective lenses	
dacrostenosis is treated as in the general population	
recurrent otitis media may be treated with tympanotomy tubes	
dental care may require assistance with daily brushing and flossing	
orthodontic referral should be considered for treatment of malocclusion	
infants often benefit from feeding therapy	
urinary tract abnormalities	C4021821//Abnormality of the urinary system//HPO
hypothyroidism is treated with oral thyroxine therapy	
treatment is life long, including during pregnancy	
d-penicillamine (chelator)	
pyridoxine must be given along with d-penicillamine	
zinc (metallothionein inducer)	
antioxidants	C0003402//Antioxidants//MTH
, vegetarians) consult with a trained dietitian	
no specific treatment exists for wss	
all treatment is symptomatic	
note: standard replacement hormonal treatment will not promote fertility	
low igf-1	
standard treatment	
l-thyroxine replacement therapy	
ectodermal	C0013574//Ectoderm//MTH	C0521458//Ectodermal//MTH
treatment is symptomatic and cosmetic only	
movement disorders	C0026650//Movement Disorders//MTH
benzodiazepines, especially clonazepam	
its use in wss has not been documented	
dysarthria	C0013362//Dysarthria//MTH
consultation with a speech therapist may be helpful	
nutritional management by a knowledgeable nutritionist is helpful	
treatment is symptomatic and should be tailored to each patient	
orthopedic management of leg length discrepancy	
surgical correction of polydactyly	
cataract extraction and correction of vision	
dermatologic management of skin lesions	
hypohidrosis	C0020620//Hypohidrosis//MTH
some individuals may benefit from "cooling vests	
hypodontia	C0020608//Hypodontia//MTH
orthodontics may be necessary	
dental implants in adults can support aesthetic and functional dentition	
lubrication eye drops can be helpful for dry eyes	
no formal management guidelines exist	
the following are general considerations	
hypogammaglobulinemia is treated with ivig	
treatment with antiepileptic agents	
many individuals with periventricular nodular heterotopia have dyslexia	
pharmacologic treatment of dystonia	
anticholinergic agents and benzodiazepines	
the benzodiazepine associated with the best response is clonazepam	
zolpidem	C0034255//Pyridines//MTH	C0078839//zolpidem//MSH
risperidone seems less effective than haloperidol in controlling dystonia	
pharmacologic treatment of parkinsonism	
surgical treatment of dystonia and parkinsonism	
optical devices	C2350274//Optical Devices//MSH
pharmacologic	C0031330//Pharmacology//MTH	C0205464//pharmacological//MTH
total parenteral nutrition may be required	
institute appropriate antimicrobial therapy for infections	
treat lymphomas and gi cancer	
the following treatments are recommended:	
early intervention programs and special education for developmental delays	
premalignant lesions (e	
this involves electrodesiccation/curettage or surgical excision	
calcification of ligaments and tendons	
however, no controlled studies have been reported	
recurrent bacterial infections are treated with standard antibiotics	
standard management is recommended for the following:	
behavioral and psychiatric problems	
kyphoscoliosis	C0345392//Congenital kyphoscoliosis//MTH	C0575158//Kyphoscoliosis deformity of spine//MTH	C0600033//Acquired Kyphoscoliosis//MTH
eye problems	C0262477//Eye problem//MTH
testosterone-replacement therapy	
gynecomastia	C0018418//Gynecomastia//MTH	C1963120//Gynecomastia Adverse Event//MTH
regression of gynecomastia may occur with testosterone replacement therapy	
